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RATIONALE FOR THIS THESIS 
 
Healthcare systems increasingly strive to put patients at the center of care [1]. 
Information about patients’ perceptions of their health and their experiences are 
important to provide excellent patient-centered care [2]. Patient-reported 
outcomes (PROs) are a powerful tool to assess and understand patients’ 
experiences and provide insight in their health, quality of life, functional status, or 
symptoms associated with their disease, its treatment and the care they received 
[3]. Since 2004, the Patient Reported Outcomes Following Initial treatment and 
Long term Evaluation of Survivorship (PROFILES) registry has been used to collect 
PROs among more than 20,000 short- and long-term cancer survivors in the 
Netherlands. PROFILES is linked directly to clinical data from the population-based 
Netherlands Cancer Registry [4]. Previous PROFILES studies among 1,444 
lymphoma survivors have shown that patients who have or ever had lymphoma 
may experience substantial physical and psychosocial problems due to the cancer 
and its treatment [5,6]. These problems include – but are not limited to – fatigue, 
neuropathy, cognitive limitations, and psychological distress [6-9]. In addition, it 
has been demonstrated that up to one third of lymphoma survivors were not 
satisfied with the information they received and would have liked more information 
about, for example, adverse problems [10]. 
 
Starting point of this thesis were the adverse problems experienced by a substantial 
part lymphoma survivors, with a special focus on psychological distress. It is 
expected that the presence of adverse problems may result in an increasing 
burden on healthcare services in hematology. Self-management interventions 
intend to enhance patients’ knowledge and skills and empower them to self-
manage their cancer-related problems. The overarching research questions to be 
answered in this thesis are which factors are associated with psychological distress, 
and whether self-management interventions may have a beneficial effect on PROs.  
LYMPHOMA: SUBTYPES, SURVIVAL AND PREVALENCE 
 
Lymphomas are cancers that originate from lymph nodes and the lymphatic 
system and have classically been divided into two distinct groups: Hodgkin 
lymphoma (HL) and non-Hodgkin lymphoma (NHL) [11]. Indolent or low-grade 






and need treatment from time-to-time [7,12,13], whereas aggressive or high-grade 
lymphomas grow at a faster rate and usually require immediate treatment [14].  
 
Improvements in the treatment of lymphoma have led to improved survival, also 
in the Netherlands [15-18]. Approximately 85% of patients with HL and indolent 
lymphomas are expected to be alive at five years after diagnosis, whereas this is 
62% of patients with aggressive lymphomas [19]. Survival statistics vary, depending 
on stage of disease, treatment and age of the patient. The improved survival results 
in an increasing number of individuals who have ever been diagnosed with 
lymphoma. In 2020, there will be more than 40,000 individuals in the Netherlands 
who have or ever had lymphoma [19,20], an increase of approximately 65% 
compared with 2010. Moreover, in the United States, there will be over one million 
lymphoma survivors in 2020 [21]. 
 
The term ‘lymphoma survivor’ refers to all individuals who have ever been 
diagnosed with lymphoma and thus includes individuals diagnosed with lymphoma 
in the past as well those who were recently diagnosed [22]. Nevertheless, not all 
individuals who have been diagnosed with lymphoma identify themselves with the 
term ‘survivor’, especially not individuals with indolent and thus more chronic types 
of lymphoma. As the studies included in this thesis include patients from various 
phases of the cancer care continuum [23], the term ‘patients’ and ‘survivors’ are 
being used interchangeable in this thesis. 
PSYCHOLOGICAL DISTRESS AND ADJUSTMENT AFTER CANCER 
 
Improved survival is associated with increasing awareness that PROs are an 
important aspect of cancer survivorship [24], especially because approximately 
30% of lymphoma survivors continue to experience adverse long-term physical 
and psychological problems. Previous research has revealed that up to a quarter 
of lymphoma survivors experienced a state of emotional suffering characterized by 
symptoms of depression and anxiety [5]. Psychological distress involves a range of 
feelings from commonly experienced vulnerability, fears, and sadness to problems 
that can become disabling, such as anxiety, depression, social isolation and panic 
[25]. For the majority of survivors, feelings of psychological distress diminish after 
diagnosis and treatment and they do not experience persistent psychological 






psychological response that has a persistent impact on their functioning and quality 
of life [5,26,27]. 
 
Receiving a cancer diagnosis is a stressful experience that requires adequate 
coping strategies to maintain balance. Whether or not patients experience adverse 
problems highly depends on their coping resources. Lazarus and Folkman's theory 
of stress and coping was used as the theoretical framework [28]. Psychological 
well-being is determined by the relative balance between the stress posed by the 
stressful situation – the cancer experience – and the resources available to cope 
with this stressful situation (Figure 1), which is dynamic and may fluctuate over time 
[29,30]. When coping resources are inadequate, patients may be at risk for adverse 
problems, even when the stress posed by the cancer experience appears to be 
low. Alternatively, the risk for adverse problems may be low when the stress posed 
by the cancer experience appears to be considerable and/or the resources are 
considerable as well [28-30]. Serious psychological distress occurs when the 
experience is perceived as threatening and is either exceeding or taxing the 
patient’s resources to cope with the experience [28].  
 
 
Figure 1. The transactional stress-coping model of Lazarus and Folkman 
SELF-MANAGEMENT AND SELF-MONITORING 
 
Effective self-management provides patients with the ability to ‘monitor their 
condition and to effect the cognitive, behavioral, and emotional responses that are 
needed to keep up a good quality of life’ [31]. It provides knowledge and skills to 
manage the physical and psychosocial aspects of (chronic) illness [32]. Effective 
self-management contributes to empowering patients to take responsibility for 
their own health, improving patients’ health and well-being, and reducing patients’ 
need to have constant visits to health professionals [33,34]. Self-management does 
Reappraisal: pacing and learning 
Secondary appraisal: 
perception of available 
resources 
Primary appraisal: 
Interpretation of the 
threatening tendency  









not mean the exclusion of healthcare providers, but it represents a new model of 
active collaboration between patients and healthcare providers [35]. Self-
management is considered crucial to bridge the gap between the needs of cancer 
survivors and the ability of healthcare services to meet those needs [23,32]. An 
important element of self-management is monitoring one’s physical and 
psychosocial functioning and making appropriate management decisions based 
on the results of self-monitoring [36]. PROs are not only useful at population level 
for aggerating population-based or trial data, but have also the potential to 
improve care at the individual patient level for patients with cancer [37]. Regular 
screening of physical and psychosocial symptoms can help identify symptoms or 
problems and enable patients to become more involved in managing their own 
health [38,43]. Self-monitoring motivates and maintains behavior change by 
promoting self-efficacy, increasing awareness, and monitoring progress [35]. In 
addition, it has been demonstrated that feedback on PROs can result in improved 
symptom detection and improved communication between patients and health 
care providers [38-42,44-48]. Feedback on PROs however was mostly provided to 
healthcare providers, who may not always see the urgency of specific problems or 
may forget to dicuss these topics with the patients. Alternatively, providing 
feedback on PROs directly to patients can enable them to self-monitor their 
symptoms and reassure them that their symptoms are not abnormal, or motivate 
them to discuss their symptoms with healthcare providers.  
SELF-MANAGEMENT INTERVENTIONS 
 
The theoretical framework of Greenhalgh et al demonstrated that providing 
feedback on PROs is particularly effective in the identification of problems and 
unmet needs, but intervening steps may be necessary to actually improve health 
outcomes [49]. Self-management interventions typically include educational 
components or intervention techniques that can help patients identify and manage 
persistent adverse problems [32] and motivate them to influence their health 
[35,50]. Information provision, or education, is an essential component of self-
management interventions as patients need information about their disease.  
 
Information provision  
Knowledge of the disease and its management can make the cancer experience 
seem less mysterious and frightening. Adequate information provision about the 







stressful situation [51,52], and subsequent reductions in anxiety and mood 
disturbances [53]. It has previously been demonstrated that one third of patients 
with lymphoma are not satisfied with the information they received and would have 
liked to receive more information [10]. In addition, previous literature has shown 
that the majority of patients wants as much information as possible and tend to 
actively search for information [54]. This group of information seeking patients has 
been classified as ‘information monitors’ [55]. Alternatively, other patients seem to 
actively avoid information and are uncomfortable with large amounts of 
information. This group of information avoiding patients has been classified as 
‘information blunters’ [55]. Thus, providing all available information may enhance 
coping abilities and reduce the risk for adverse problems in some patients, whereas 
it may increase fears and worries for others [30]. Therefore, it is important to pay 
more attention to patient-centered information provision and to tailor information 
provision to the needs of patients. 
 
Supporting skills 
In addition to education, effective self-management of adverse cancer-related 
physical and psychological problems requires patients to develop a new set of skills 
that may not be in their usual repertoire of health behaviors [56]. This requires 
patients to be able to monitor their psychological adjustment and to potentially 
alter the cognitive, behavioral, and emotional responses in order to maintain a 
good quality of life [31,57]. Interventions to support self-management should 
therefore contain more than solely psychoeducation – in the form of the provision 
of systematic, relevant, broad, and up-to-date information – and also include 
components that can produce behavior change. Cognitive behavioral therapy 
(CBT) aims to alter dysfunctional perceptions and coping strategies. CBT 
techniques include – but are not limited to – psychoeducation, self-monitoring, 
goal setting, cognitive restructuring, coping and process evaluation [58,59]. CBT 
techniques can be incorporated into self-management interventions to increase 
the repertoire of self-management skills that cancer survivors can apply to manage 
adjustment to cancer. The process in which patients change their underlying 
appraisals that contribute to poor adjustment to cancer fits in the reappraisal phase 
of the transactional stress-coping model of Lazarus and Folkman (Figure 1) [28]. 
Cognitive reappraisal is a stress-coping technique based on CBT that helps patients 
to identify negative thoughts and behavior patterns and then change the related 
thoughts and underlying beliefs to reflect more positivity when dealing with 





their thoughts have fallen into and they change the pattern to one that is more 
effective.  
 
Summarized, self-management interventions will increase patient involvement in, 
and responsibly for, their own health and care [35]. This may subsequently result 
in decreased burden on the health care system and will support more optimized 
use of limited resources.  
THE LYMPHOMA INTERVENTION [LIVE] TRIAL 
 
In this thesis, two interventions that enable patients to participate in managing their 
care along the cancer care continuum are discussed within the Lymphoma 
InterVEntion (LIVE) trial. The LIVE trial consists of 1) feedback on PROs, and 2) a 
web-based self-management intervention named Living with lymphoma. The PRO 
feedback has the potential to enable patients to monitor their symptoms and 
compare them with peers, which may reassure them that what they experience is 
‘normal’ or may empower them to take action. The web-based self-management 
intervention Living with lymphoma is an adaptation from the evidence-based 
BREAst cancer e-healTH (BREATH) intervention, that was developed to facilitate 
adjustment after curative breast cancer [61]. Access to BREATH was found to be 
associated with reduced psychological distress, and higher self-efficacy among 
breast cancer survivors [62]. The web-based self-management intervention Living 
with lymphoma intents to enhance knowledge and skills and empower patients to 
better manage their cancer-related problems. 
AIMS AND ORGANIZATION OF THIS THESIS 
 
The chapters in this thesis describe the process from making an inventory of factors 
associated with psychological distress among lymphoma survivors to the 
development and evaluation of an intervention that aims to increase resources to 
cope with the stress and burden posed by the cancer experience and reduce 
psychological distress. 
  
Part I  Inventory: factors associated with psychological distress  
This thesis starts with an inventory of factors that are associated with psychological 
distress among lymphoma survivors. Considering that coping strategies greatly 







psychological distress [63], the aim of Chapter 2 is to investigate which coping 
strategies – but also sociodemographic and clinical factors – are associated with 
an increased risk of psychological distress among patients with lymphoma. Further, 
the aim of Chapter 3 is to evaluate the use of healthcare services among 
distressed compared to non-distressed lymphoma survivors. In addition, 
sociodemographic and clinical characteristics associated with increased healthcare 
use in lymphoma survivors are identified.  
 
Part II  Intervention: Lymphoma InterVEntion [LIVE] trial  
In Chapter 4, we investigate whether patients with lymphoma wished to receive 
PRO feedback, including the option to compare their scores with those of their 
peers, and how this feedback was evaluated. The rationale and study design of the 
Lymphoma InterVEntion [LIVE] trial are presented in Chapter 5. Further, the main 
effects of the interventions on self-management skills, satisfaction with information 
provision, and psychological distress are described in Chapter 6. In addition, the 
aim of Chapter 7 is to identify the reach of a web-based self-management 
intervention within the context of an RCT. Thereafter, in Chapter 8, the main 
findings and methodological considerations of this thesis are discussed, and 
implications for clinical practice and future research are outlined. 
METHODS: RCT EMBEDDED WITHIN A POPULATION-BASED REGISTRY 
 
For the LIVE-trial, patients with lymphoma were selected from the population-
based Netherlands Cancer Registry (NCR) that routinely collects data on 
sociodemographic and clinical characteristics. Data collection regarding PROs was 
conducted within the PROFILES registry, a tool that enables data collection 
management; from inviting patients to participation in studies, to collecting PRO 
data via web-based or mailed questionnaires and linking these data with clinical 
data from the NCR [4]. Patients who completed the web-based questionnaire were 
enrolled in the trial and automatically randomized to one of the RCT arms. 
Alternatively, patients who completed a paper questionnaire were observationally 
followed within the PROFILES lymphoma registry.  
 
Results from the studies within this thesis are based on data from the LIVE-trial, 
except for the results of Chapter 3 and Chapter 4, which are based on data from 
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Up to a quarter of patients with lymphoma experience persisting levels of psychological 
distress. This study aims to examine the extent to which personality traits and coping 
strategies, separately and together, are associated with psychological distress among 
patients with lymphoma, controlling for sociodemographic and clinical characteristics. 
 
Methods 
A population-based sample of patients with lymphoma, selected from the Netherlands 
Cancer Registry (NCR) was invited to complete a questionnaire about psychological 
distress (HADS), personality (BFI) and coping strategies (MAC). Sociodemographic and 
clinical data were retrieved from the NCR. Multivariable linear regression models were 
constructed to assess the unique variance in psychological distress explained by 
personality traits and coping strategies separately and together. 
 
Results 
A total of 456 patients completed the questionnaire (51%). The mean age was 65 years, 
64% were male and 17% reported psychological distress. Of sociodemographic and 
clinical characteristics, comorbidity (β=.14, P<.001) and age (β=-.10, P=.03) were 
independently associated with psychological distress. In addition, of personality traits, 
only neuroticism was related to psychological distress (β=.43, P<.001). Furthermore, 
coping styles helplessness/hopelessness (β=.30, P<.001) and anxious preoccupation 
(β=.12, P=.01) were associated with more psychological distress, whereas avoidance was 
associated to less psychological distress (β=-.09, P=.01). 
 
Conclusions  
In conclusion, besides comorbidity and age, both personality traits – in particular 
neuroticism – and coping strategies including helplessness/hopelessness, anxious 
preoccupation, and avoidance were significantly independently associated with 
psychological distress. Unlike personality, coping strategies are considered to be 
changeable and could be targeted by interventions such as cognitive-behavioral 








Each year, over 4,500 patients in the Netherlands and 100,000 patients in the US 
are diagnosed with lymphoma including chronic lymphocytic leukemia (CLL) [1,2]. 
Approximately 40% of lymphoma diagnoses are indolent diseases and are not 
curable, but can be controlled and managed for long periods of time [3]. 
 
Receiving a cancer diagnosis is considered to be a very stressful experience. 
According to the stress-coping theory of Lazarus and Folkman, psychological well-
being is determined by the balance between the stress posed by the cancer 
experience and the resources available to cope with this experience [4,5]. Whereas 
the majority of patients adjust well to cancer and do not report adverse 
psychological problems, up to a quarter of patients with lymphoma experience 
persistent levels of anxiety and depressive feelings, also known as psychological 
distress [6,7]. Psychological distress may lead to lower health-related quality of life 
[6] and increased healthcare use [8]. Knowledge of the predisposing factors and 
their managements may help healthcare providers to prevent or manage 
psychological distress. Previous literature has demonstrated that psychological 
distress has been associated with patient and disease-related factors, including – 
but not limited to – age, treatment and time since diagnosis [6,9-11]. It has, 
however, also been suggested that a patient’s subjective appraisal of how cancer 
and its treatment impacts their life may be a more substantial predisposing factor 
than patient or disease-related factors [12].  
 
The identification of personality traits that may predispose patients with cancer to 
experience psychological distress has been a major emphasis in psychology. 
Neuroticism is known to be the most consistent personality trait that is associated 
with psychological distress [13,14], although inconsistent results were reported 
regarding the roles of extraversion, agreeableness, conscientiousness, and 
openness [15]. Personality traits determine the way of reacting and adapting – also 
considered coping – to given situations [13,16]. Those with high scores on 
neuroticism have the tendency to experience more negative affect and are prone 
to experience more negative appraisals of cancer on their lives [13-15,17]. In 
addition, they may be less flexible in adapting their own standards and values [14]. 
Those scoring high on neuroticism tend to use more passive or nonadaptive 
coping strategies when they are confronted with a stressful situation, such as a 
cancer diagnosis, which makes it more difficult for them to adapt to cancer [14].  
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Although a large body of research exists on the relationship between personality 
and psychological distress, or the relationship between coping strategies and 
psychological distress [16,18-23], little is known about the unique variance in 
psychological distress explained by personality traits and coping strategies 
separately and together. This study aims to examine the extent to which personality 
traits and coping strategies, separately and together, are associated with 
psychological distress among patients with lymphoma, while controlling for 
sociodemographic and clinical characteristics.  
METHODS 
 
Study design, participants and recruitment procedure 
Patients who were diagnosed with Hodgkin lymphoma (HL), non-Hodgkin 
lymphoma (NHL), including CLL, as defined by the International Classification of 
Diseases for Oncology-3 codes (ICD-O-3) [24], in thirteen hospitals in the 
Netherlands were selected for participation in the Lymphoma InterVEntion (LIVE) 
trial [25] via the Netherlands Cancer Registry (NCR). Details of the LIVE-trial have 
been previously described in the protocol paper [25]. Patients who completed the 
first questionnaire online were enrolled in the trial, whereas those who completed 
the questionnaire on paper were observationally followed. This study included both 
online and paper respondents. Patients were selected approximately 9 to 18 
months after diagnosis and had to be 18 years or older. Patients who had 
deceased, were too ill, or who had serious cognitive impairment (e.g., dementia) 




Psychological distress was assessed with the 14-item Hospital Anxiety and 
Depression Scale (HADS) [26]. Each item is rated on a 4-point scale from 0 to 3. 
The sum can be scored through addition of the item scores with a range from 0 to 
42. Higher sum scores indicate higher levels of psychological distress. Patients with 
a HADS sum score ≥13 were categorized as “psychologically distressed” [27]. 
 
Personality traits were assessed with the Big Five Inventory (BFI) [28]. The BFI is a 
44-item inventory designed to measure the Big Five personality traits: neuroticism, 
extraversion, openness to experience, agreeableness, and conscientiousness. Each 





for each trait and range from 0 to 5. Each trait is assumed to represent a continuum 
from high to low on the specific attribute and is partnered with an trait on the 
opposite pole of the spectrum [29].  
 
The 40-item Mental Adjustment to Cancer (MAC) scale was used to assess 
adjustment to cancer in terms of coping strategies [30,31]. Items can be grouped 
on five categories representing different coping strategies: helplessness/ 
hopelessness, anxious preoccupation, fighting spirit, fatalism and avoidance. Each 
item is rated on a four-point scale from 1 to 4. The subscales can be scored 
separately through simple addition of the items. Higher scores represent higher 
endorsement of the coping strategy.  
 
Sociodemographic and clinical characteristics were available from the NCR that 
routinely collects data on patients’ age and sex, date of cancer diagnosis, cancer 
type, and primary treatment. Information on educational level and marital status 
was assessed in the questionnaire. Comorbidity at the time of questionnaire 
completion was assessed with an adapted version of the Self-Administered 
Comorbidity Questionnaire [32]. Patients were asked to identify comorbid 
conditions present within the past 12 months: heart disease, hypertension, arthritis, 
stroke, lung disease, diabetes, stomach disease, kidney disease, liver disease, 
anemia, thyroid disease, and rheumatoid arthritis. Positive responses were 
summed to obtain a total score that ranges from 0 to 12.  
 
Statistical analyses  
All statistical analyses were performed with SAS version 9.4 (Cary, NC, USA). Two-
sided P-values of <.05 was considered statistically significant. Differences on 
sociodemographic and clinical characteristics between respondents and 
nonrespondents, as well as differences between patients with and without 
psychological distress were compared using t-tests for continuous variables and 
chi-square tests for categorical variables. Furthermore, differences on personality 
traits and coping strategies between patients with and without psychological 
distress were compared using t-tests.  
 
Multivariable linear regression models were constructed to assess the unique 
variance in psychological distress explained by personality traits and coping 
strategies separately and together. First, a crude model was run entering only the 
covariates sociodemographic and clinical characteristics (model 1). Thereafter, 
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either personality traits (model 2) or coping strategies were added (model 3). 
Finally, personality traits and coping strategies were entered simultaneously while 
controlling for sociodemographic and clinical characteristics (model 4). 
RESULTS 
 
Patients’ characteristics  
In total, 456 respondents completed the questionnaire (51%). The 
sociodemographic and clinical characteristics of respondents are summarized in 
Table 1. Respondents were more often male than nonrespondents (64% vs 56%; 
P=.02) and more often received active treatment (75% vs 66%, P=.01). No 
differences regarding age, cancer type and time since diagnosis were observed 
between respondents and nonrespondents (P>.05). Respondents were on average 
64.5 years old, with a mean time since diagnosis of 14.2 months. More than half of 
the respondents followed medium education (57%) and the majority had a partner 
(79%). In addition, two thirds of the respondents reported one or more comorbid 
conditions, the most common being arthritis (24%) and hypertension (23%). In 
total, 17% of the respondents scored above the cutoff for psychological distress 
(N=79). 
 
Differences between patients with and without psychological distress 
Patients who scored above the cutoff for psychological distress (≥13) were less 
often highly educated (20 vs 38%; P=.01; Table 1) and reported more comorbid 
conditions (1.9 vs 1.1, P<.01). No statistically significant differences according to 
psychological distress were found between cancer types (P=0.11). In addition, no 
differences regarding sex, having a partner, time since diagnosis, and primary 
treatment were observed between those with and without psychological distress 
(P>.05). 
 
Association between personality, coping and psychological distress 
The crude model showed that sociodemographic and clinical covariates accounted 
for approximately 9.7% of the variance in psychological distress. Comorbidity was 
the greatest factor associated with psychological distress in this model (β=.28, 
P<.001). In addition, higher age was associated with less psychological distress (β=-






Table 1. Sociodemographic and clinical characteristics of patients with psychological distress 
(N=79) and patients without psychological distress (N=377) 









 N=79 N=377  N=456 
 n(%) n(%) P  
Sociodemographic characteristics     
Sex   .89  
Male 51 (65) 241 (64)  291 (64) 
Female 28 (35) 137 (36)  165 (36) 
Age: mean (SD) 63.5 (13.8) 64.7 (13.4) .48 64.5 (13.5) 
Education#   .01  
Low  7 (9) 26 (7)  33 (7) 
Medium 56 (71) 205 (55)  260 (57) 
High  16 (20) 143 (38)  159 (35) 
Unknown  0 (0) 4 (1)  4 (1) 
Partner (yes) 59 (78) 296 (80) .70 354 (79) 
Clinical characteristics     
Months since diagnosis: mean (SD) 14.5 (3.4) 14.2 (3.2) .45 14.2 (3.3) 
Cancer type   .11  
HL 8 (10) 38 (10)  46 (10) 
NHL-HG 39 (49) 220 (58)  259 (57) 
NHL-LG 28 (35) 87 (23)  114 (25) 
CLL 4 (5) 33 (9)  37 (8) 
Treatment   .75  
Active surveillance 20 (25) 93 (25)  112 (25) 
Active treatment  58 (73) 283 (75)  341 (75) 
Unknown 1 (1) 2 (1)  3 (1) 
Comorbid conditions: mean (SD) 1.9 (1.3) 1.1 (1.2) <.01 1.3 (1.2) 
Most frequent comorbid conditions     
Arthritis  28 (35) 80 (22) <.01 108 (24) 
Hypertension  23 (29) 82 (22) .19 105 (23) 
Heart disease 24 (31) 67 (18) .01 91 (20) 
Note. Bold type indicates statistical significance (P<.05). 
Abbreviations: CLL, chronic lymphocytic leukemia; HL, Hodgkin lymphoma; NHL-HG, high-grade non-
Hodgkin lymphoma; NHL-LG, low-grade non-Hodgkin lymphoma; SD, standard deviation. 
# For education, low indicates none/primary school; medium, lower general secondary education/ 









When personality traits were added to the crude model (model 2), the model 
accounted for 42.8% of the variance in psychological distress. Of personality traits 
only neuroticism was statistically significantly associated with more psychological 
distress (β=.57, P<.001). In addition, comorbidity and higher age remained 
associated with psychological distress, whereas the association of high education 
was no longer statistically significant in this model.  
 
When coping strategies were added to the crude model (model 3), the model 
accounted for 38.8% of the variance in psychological distress. Helplessness/ 
hopelessness (β=.36, P<.001) and anxious preoccupation (β=.23, P=.01) were 
statistically significantly associated with more psychological distress, whereas 
higher fighting spirit (β=-.12, P=.01) and avoidance (β=-.10, P=.02) were associated 
with less psychological distress. Also in this model, comorbidity and higher age 
remained statistically significantly associated with psychological distress. 
 
Entering both personality traits and coping strategies simultaneously into the crude 
model, while controlling for sociodemographic and clinical characteristics (model 
4), the model accounted for 50.6% of the variance in psychological distress. Also 
in this model, comorbidity remained associated with more psychological distress 
(β=.14, P<.001) and higher age with less psychological distress (β=-.10, P=.02). As 
in model 2, with personality traits added, only neuroticism was significantly 
associated with psychological distress (β=.43, P<.001). In addition, as in model 3, 
helplessness/hopelessness (β=.30, P<.001) and anxious preoccupation (β=.12, 
P=.01) were still associated with more psychological distress, while avoidance was 
associated with less psychological distress (β=-.09, P=.01). However, fighting spirit 
was no longer statistically significantly associated with psychological distress, when 
personality traits and coping strategies where added to the model simultaneously, 
which seems to indicate that the association between fighting spirit and 
psychological distress might be fully explained by personality traits. In addition, the 
association between neuroticism and psychological distress became weaker when 
coping strategies were added to the model, as well as the association between 
anxious preoccupation and psychological distress became weaker when 
personality traits were added. This might suggest that the association between 







Table 2. Multivariable linear regression models of characteristics associated with 
psychological distress among patients with lymphoma 
 Model 1  Model 2  Model 3  Model 4 
 β P  β P  β P  β P 
Sociodemographic characteristics          
Age -.12 .03  -.10 .02  -.12 .01  -.10 .03 
Male sex .001 .97  .03 .38  -.01 .80  .02 .65 
Education#            
Low  -.002 .96  -.02 .69  .005 .91  -.01 .80 
Middle (ref)            
High  -.14 .003  -.02 .58  -.07 .08  -.02 .61 
Clinical characteristics            
Cancer type            
HL .02 .99  .005 .90  .06 .14  .04 .29 
NHL-HG (ref)            
NHL-LG .06 .66  .02 .59  .02 .66  .02 .64 
CLL -.07 .11  -.04 .26  -.07 .07  -.04 .23 
Comorbidity  .28 <.001 .19 <.001  .16. <.001  .14 <.001 
Personality             
Neuroticism    .57 <.001     .43 <.001 
Extraversion    -.04 .37     .03 .47 
Openness    .04 .32     .04 .32 
Agreeableness     -.02 .67     -.02 .71 
Conscientiousness    -.05 .27     -.02 .63 
Coping strategies            
Fighting Spirit       -.12 .01  -.004 .92 
Anxious Preoccupation       .23 <.001  .12 .01 
Helplessness/Hopelessness      .36 <.001  .30 <.001 
Fatalism       .05 .30  .02 .69 
Avoidance       -.10 .02  -.09 .01 
Note. Bold type indicates statistical significance (P<.05). 
Abbreviations: CLL, chronic lymphocytic leukemia; HL, Hodgkin lymphoma; NHL-HG, high-grade non-
Hodgkin lymphoma; NHL-LG, low-grade non-Hodgkin lymphoma 
# For education, low indicates none/primary school; medium, lower general secondary education/ 
vocational training; and high, pre-university education/high-level vocational training/university. 
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The results of the present study indicated that besides comorbidity and age, both 
personality traits – in particular neuroticism – and coping strategies including 
helplessness/hopelessness, anxious preoccupation, and avoidance were 
significantly associated with psychological distress. The association between 
personality traits and psychological distress might be partially explained by anxious 
preoccupation.  
 
The crude model – with sociodemographic and clinical characteristics – accounted 
for approximately 10% of the variance in psychological distress. Changes in the 
variance of the multivariate analysis suggested that the associations of 
sociodemographic and clinical characteristic were relatively small, whereas the 
associations of psychological factors, such as personality traits and coping 
strategies, were much greater. The model in which only personality traits were 
added to the crude model (model 2) accounted for approximately 43% of the 
variance, whereas the model in which only coping strategies were added to the 
crude model (model 3) accounted for approximately 39% of the variance. Finally, 
the fourth model, in which both personality traits and coping strategies were added 
together to the crude model, accounted for approximately 51% of the variance in 
psychological distress among patients with lymphoma. 
 
When looking at sociodemographic and clinical characteristics, our results revealed 
that older patients experienced less psychological distress. Younger patients may 
experience more problems with adjustment to cancer, for example because of the 
stress of loss of fertility, child care, healthcare expenses, missed work because of 
their cancer treatment or side effects, and lack of financial or employment stability 
[33]. They might therefore be more vulnerable to experience psychological distress 
compared to older patients. In addition, patients who have more comorbidities 
experienced more psychological distress. The presence of comorbidities may 
interact with cancer to result in greater overall symptom and emotional burden. 
 
Of the five personality traits, only neuroticism was statistically significantly 
associated with psychological distress, both in the model with only personality 
(model 2), as well as while controlling for coping strategies (model 4). Patients 
scoring high on neuroticism respond worse to stressful situations, experience more 





minor frustration as hopelessly difficult [34]. The results of this study might suggest 
that the association between neuroticism and psychological distress may be 
partially explained by coping strategies. How patients cope with and adjust to 
cancer is reportedly associated with psychological distress. Indeed, our results 
showed that patients with passive coping strategies including helplessness/ 
hopelessness or anxious preoccupation experienced more psychological distress, 
which is in line with studies among patients with different cancer types 18,20,21. 
Passive coping refers to a sense of helplessness in dealing with the stressor and 
relying on others to resolve the problems [35]. On the other hand, fighting spirit 
has been consistently shown to be associated with less psychological distress 
[30,36,37], which seemed to be supported by the results in our third model, in 
which coping strategies were added separately. However, in the fourth model – 
with coping strategies and personality traits added together – fighting spirit was 
no longer statistically significantly associated with psychological distress. This seems 
to indicate that the association between fighting spirit and psychological distress 
may be fully explained by personality traits. Furthermore, avoidance was associated 
with less psychological distress. This most likely due to the measurement of this 
coping style, as our measurement included a single item, whereas it has been 
suggested that this coping style should be measured in other ways [30,38]. 
 
The significance of coping strategies in relation to psychological distress was 
supported in our multivariable analysis, as it accounted for a large part of the 
variance in psychological distress. Unlike personality, coping strategies are 
considered to be changeable and could be targeted by interventions such as 
cognitive-behavioral therapy (CBT) [39]. Targeting the modification of 
dysfunctional thoughts and beliefs by cognitive restructuring is a common strategy 
in CBT [40]. In addition, CBT is frequently used to modify behavioral tendencies 
(e.g., rumination) of individuals scoring high on neuroticism [41].  
 
This study had several limitations. Although information was available regarding 
the sociodemographic and clinical variables of nonrespondents, it remains 
unknown why they declined to participate. Comparing respondents and 
nonrespondents indicated differences in sex and primary treatment. This perhaps 
resulted in a small selection bias, although these characteristics were not 
significantly associated to psychological distress. In addition, the cross-sectional 
design of this study limits the ability to draw conclusions about the direction of the 
relationships between the study variables. Nevertheless, an important strength of 
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the study is its population-based sampling frame that facilitates the extrapolation 
of the results to a broad range of patients. 
 
In conclusion, besides comorbidity and age, both personality traits – in particular 
neuroticism – and coping strategies helplessness/hopelessness, anxious 
preoccupation, and avoidance were significantly independently associated with 
psychological distress. Unlike personality, coping strategies are considered to be 
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Follow-up care for a growing population of survivors of lymphoma and chronic 
lymphocytic leukemia (CLL) together with the adverse effects these survivors may 
experience as a result of their cancer and treatment have led to more pressure being 
placed on health care services. The objectives of the current study were to: 1) compare 
the use of medical care services by survivors with that of a normative population; 2) 
evaluate the use of medical and psychosocial care services among distressed and non-
distressed survivors; and 3) identify associated sociodemographic and clinical factors.  
 
Methods 
Survivors of lymphoma and CLL diagnosed between 1999 and 2012 were selected via 
the population-based Netherlands Cancer Registry and completed the Hospital Anxiety 
and Depression Questionnaire and questions on health care. Outcomes were compared 
to an age-matched and sex-matched normative population. 
 
Results  
A total of 1444 survivors responded (69%). Survivors of lymphoma and CLL contacted 
their general practitioner (3.8 vs 2.3, P<.001) and medical specialist (5.7 vs 1.6, P<.001) 
more often within the last year compared with a normative population. In addition, 
psychologically distressed survivors had even more medical contacts and received 
psychosocial care more often compared with non-distressed survivors. In addition to 
psychological distress, comorbidity, female sex, and older age were found to be 
associated with greater use of medical services, whereas younger age was associated 
with receiving psychosocial care.  
 
Conclusions  
Survivors of lymphoma and CLL, especially those who are psychologically distressed, 
report an increased use of health care services compared with a normative population. 
Further studies are needed to explore whether the use of widely applicable psychosocial 









Due to advances in the treatment of lymphoma and chronic lymphocytic leukemia 
(CLL), a rising incidence, and aging of the population, the number of patients who 
are living with a history of lymphoma or CLL continues to grow [1-6]. It is expected 
that in 2020 there will be approximately 40,000 patients in the Netherlands who 
either are cured of their lymphoma or are living with it as a chronic disease [7], an 
increase of approximately 65% compared with 2010.  
 
As a result of the disease and its treatment, survivors of lymphoma and CLL are at 
risk of experiencing adverse physical and psychosocial effects such as second 
malignancies, neuropathy, persistent fatigue, cognitive impairment and 
psychological distress [8-14]. Therefore, regular follow-up care with monitoring of 
long-term and late adverse effects is extremely important [15]. Follow-up care for 
a growing population of survivors of lymphoma and CLL together with various 
adverse effects that these survivors may experience has resulted in more pressure 
being placed on health care services [16].  
 
Psychological distress is a significant psychosocial issue for at least 25% of patients 
with lymphoma and CLL [12,17]. Psychological distress includes persistent levels of 
anxiety, depressive feelings and fears [18], and has a great impact on a patient’s 
daily life. Some patients experience psychological distress as somatic symptoms 
such as headaches, sleeping problems and gastrointestinal complaints and seek 
medical help for these issues [18-22]. Research has suggested that patients with a 
background of psychological problems contact their general practitioner (GP) 
nearly twice as often for both psychological and somatic symptoms compared with 
patients without a background of psychological problems [23]. Evidence has 
demonstrated that integrated psychosocial care, which combines psychological 
screening and psychological interventions, is an effective means of treating 
psychological distress [18,24]. However, psychosocial care appears to be 
suboptimal [18,25]. Although patients with high levels of distress are more likely to 
receive psychosocial care [25,26], nearly one-half of distressed cancer survivors did 
not [26]. 
 
To our knowledge to date, the association between psychological distress and the 
use of medical and psychosocial care services rarely has been studied among 
survivors of lymphoma and CLL. Insights regarding this association will provide 
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information concerning the potential value of screening for psychological distress 
and the use of psychosocial interventions in the care of patients with lymphoma. 
Therefore, the objectives of the current study were to: 1) compare the use of 
medical care services by survivors with that of a normative population without 
cancer; 2) evaluate the use of medical and psychosocial care services among 
distressed and non-distressed survivors of lymphoma and CLL; and (3) identify 
factors that are associated with use of medical and psychosocial care services 
among survivors of lymphoma and CLL. We hypothesized that survivors of 
lymphoma and CLL overall have more medical contacts compared with a 
normative population without cancer, and that distressed survivors have more 
medical contacts and receive more psychosocial care than non-distressed 
survivors. Furthermore, based on the model of health services use of Andersen and 
Newman [27], we hypothesized that not only psychological distress, but also 
individual sociodemographic and clinical factors such as age, sex, education level, 
cancer type, treatment, and comorbidity, are associated with the use of health care.  
METHODS AND DESIGN 
 
Setting and population 
Data from the Eindhoven area of the population-based Netherlands Cancer 
Registry were used to select patients with a diagnosis of Hodgkin lymphoma, non-
Hodgkin lymphoma, and CLL between January 1999 and May 2012 [28]. Only 
patients aged ≥18 years at the time of diagnosis were included. Patients who had 
died, were in transition to terminal care, or who had serious cognitive impairment 
(i.e., dementia) were excluded. We used the term ‘survivors’ to include all living 
individuals who ever received a diagnosis of lymphoma or CLL [29].  
 
Study measures 
Two open questions were asked to assess the use of medical care services: 1) “How 
often did you contact a GP in the past 12 months?” and 2) “How often did you visit 
a medical specialist in the past 12 months?”. Patients also were asked whether they 
received care after their cancer treatment (no/yes). If they answered yes, patients 
could choose multiple additional care services from a list. Psychosocial care was 
defined as receiving care from a psychologist, social worker, oncological 
rehabilitation, or oncology nurse. 
 
The 14-item Hospital Anxiety and Depression Scale (HADS) was used to assess 





HADS-anxiety and HADS-depression. Items were scored on a 4-point scale. A sum 
score was obtained by adding all items, with a higher score indicating more distress 
[31]. Survivors with a HADS score ≥13 were categorized as “distressed” [32]. 
 
Comorbidity at the time of the survey was categorized according to the adapted 
Self-administered Comorbidity Questionnaire (SCQ) [33]. Patients were asked to 
identify comorbid conditions present within the past 12 months. Positive responses 
were summed to obtain a total score (range, 0-13). 
 
Sociodemographic characteristics and clinical information were available from the 
Netherlands Cancer Registry, which routinely collects data on patient age and sex, 
date of cancer diagnosis, cancer type, and treatment. Information concerning 




Data were collected within Patient-Reported Outcomes Following Initial Treatment 
and Long-term Evaluation of Survivorship (PROFILES). Details regarding the data 
collection method have been described previously [34]. In May 2009, patients 
diagnosed between January 1999 and January 2009 were included in the study and 
received the first questionnaire. In November 2009, May 2011, May 2012, and May 
2013 patients newly diagnosed up to June 1, 2012, subsequently were invited to 
participate and all completed a baseline questionnaire.  
 
Normative population 
Data regarding a normative population were obtained from CentERpanel, an 
online household panel that is representative for the Dutch population. The 
process of the annual collection of data, which was initiated in 2009 by our study 
group, has been described elsewhere [35]. Data collected in 2011 included the 
assessment of health care use. From this normative population, an age-matched 
and sex-matched selection was made to compare health care use with that of 
survivors of lymphoma and CLL. For matching, 14 strata were formed using sex 
and age (7 categories). Within each stratum, a maximum number of individuals 
from the reference cohort were randomly matched according to the strata 
frequency distribution of the patients. This resulted in 563 matched cancer-free 
individuals for the 1444 survivors of lymphoma and CLL who completed the 
baseline questionnaire.  
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All comparisons of the number of medical contacts were adjusted for age, sex, and 
comorbidity. Continuous variables were compared using analysis of variance and 
categorical data were compared using chi-square tests. Multivariable logistic 
regression analyses were performed to investigate the independent association 
between sociodemographic, clinical and psychological variables and health care 
use. Statistical significance was set at P<.05 and analyses were performed using 




Of the 2101 survivors of lymphoma and CLL who were invited to participate, 1,444 
completed the questionnaire (69%). Respondents on average were older 
compared with non-responding survivors with unverifiable addresses (P<.01). 
Furthermore, respondents were further from diagnosis compared with non-
respondents (P<.01) (Table 1). The mean age at the time of completion of the 
questionnaire was 62.0 years, with a mean time since diagnosis of 3.3 years. 
Approximately 60% of respondents were male. Systemic therapy was the most 
frequent primary treatment (45%) (Table 1). Approximately 50% of survivors of 
lymphoma and CLL reported ≥1 comorbid conditions, with the most common 
being arthritis and hypertension. Approximately 26% of the survivors reported 
being psychologically distressed. The mean age of the age-matched and sex-
matched normative population at the time of completion of the questionnaire was 
62.0 years. Approximately 61% were male. Neatly 6 of every 10 respondents (59%) 
reported ≥1 comorbid conditions, with the most common being hypertension and 
arthritis (Table 1). Compared with the survivors, the normative population more 
often had a higher educational level (20% vs 41%; P≤.001) and less often had a 
partner (77% vs 70%; P=.001).  
 
Use of medical and psychosocial care services  
Approximately 89% of all survivors of lymphoma and CLL reported having 







Table 1. Patient characteristics of respondents (N=1,444), nonrespondents, and patients with 








 N=1,444 N=381 N=276 N=563 
 n(%) n(%) n(%)  
Characteristics     
Sex     
Male 870 (60) 223 (59) 159 (58) 341 (61) 
Female 574 (40) 158 (41) 117 (42) 222 (39) 
Age: mean (SD) 62.0 (14.5) 61.9 (16.6) 55.9 (16.8) 62.0 (14.6) 
Years since diagnosis: mean (SD) 3.3 (2.5) 2.6 (2.8) 3.4 (2.9)  
Cancer type     
HL 210 (15) 61 (16) 64 (23)  
NHL-HG 554 (38) 116 (30) 92 (33)  
NHL-LG 454 (31) 126 (33) 78 (28)  
CLL 226 (16) 78 (21) 42 (15)  
Primary treatment     
Active surveillance 340 (24) 125 (33) 78 (28)  
Systemic therapy  644 (45) 148 (39) 124 (45)  
Radiotherapy  97 (7) 25 (6) 16 (6)  
Chemoradiotherapy 248 (17) 64 (17) 52 (19)  
Unknown 115 (8) 19 (5) 6 (2)  
Self-reported comorbidity     
No comorbidity 652 (45)   228 (41) 
1 comorbidity 371 (26)   177 (31) 
≥2 comorbidity  346 (24)   158 (28) 
Missing data 75 (5)   0 (0) 
Most frequent comorbidities     
Hypertension  223 (16)   173 (31) 
Arthritis  252 (18)   118 (21) 
Education#     
Low  286 (21)   22 (4) 
Medium 804 (59)   313 (56) 
High  273 (20)   228 (41) 
Partner (yes) 1096 (77)   395 (70) 
Note. Bold type indicates statistically significantly different from respondents (P<.05). 
Abbreviations: CLL, chronic lymphocytic leukemia; HL, Hodgkin lymphoma; NHL-HG, high-grade non-
Hodgkin lymphoma; NHL-LG, low-grade non-Hodgkin lymphoma; SD, standard deviation. 
# For education, low indicates none/primary school; medium, lower general secondary education/ 
vocational training; and high pre-university education/high level vocational training/university. 
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Compared with an age-matched and sex-matched normative population, survivors 
of lymphoma and CLL contacted their GP more often (3.8 vs 2.3 times within the 
last 12 months, respectively; P<.001). No differences in the number of GP contacts 
between male and female survivors were observed. The average number of GP 
contacts was highest within the first year after diagnosis compared with the other 
time periods (P=.002) (Figure 1A). Distressed survivors contacted their GP more 
often than non-distressed survivors (5.2 vs 3.3 contacts, respectively; P≤.001). 
Approximately 98% of all survivors of lymphoma and CLL reported having 
contacted a medical specialist at least once within the last 12 months. Survivors 
contacted their medical specialist more often compared with an age-matched and 
sex-matched normative population (5.7 vs 1.6 contacts; P<.001). Male survivors 
contacted their medical specialist more often compared to female survivors (6.0 vs 
5.1 contacts, P=.004). Survivors of lymphoma and CLL were found to have 
contacted their medical specialist most often within the first year after diagnosis, 
with on average 7 contacts. Between 2 to 4 years, 5 to 7 years and 8 to 10 years 
after diagnosis, the average number of contacts with the medical specialist 
decreased to 5.7 contacts, 4.2 contacts, and 4.1 contacts, respectively. At all 
timepoints, distressed survivors contacted their medical specialist more often than 
survivors who were not distressed (Figure 1B). 
 
Approximately 22% of all survivors of lymphoma and CLL reported that they 
received psychosocial care after treatment. The percentage of distressed survivors 
who received psychosocial care was significantly higher compared with survivors 
without psychological distress (32% vs 19%; P≤.001). Survivors aged ≤35 years 
(adolescents and young adults) received psychosocial care more often compared 
with survivors >35 years (42% vs 20%, P≤.001), although they reported being 
distressed somewhat less often compared with older survivors (Figure 2). 
 
Factors associated with the use of psychosocial and medical care services  
Multivariable logistic regression analyses showed that survivors who received 
psychosocial care after treatment were more likely to be psychologically distressed. 
Receiving psychosocial care was also found to be associated with being female and 
of a younger age at the time of questionnaire completion. Furthermore, receiving 
psychosocial care was associated with having multiple comorbidities and treatment 










Figure 1. Differences between number of GP (A) and medical specialist (B) contacts in the 
last 12 months of distressed (N=345) and non-distressed (N=971) lymphoma and CLL 
survivors according to years since diagnosis, compared to an age- and sex-matched 
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Survivors of lymphoma and CLL who visited a GP ≥3 times within the last 12 months 
(median split) were more likely to have psychological distress. In addition, visiting 
a GP ≥3 times was found to be associated with being female, of older age, and 
reporting ≥1 comorbid conditions. Furthermore, visiting a GP ≥3 times was 
associated with a more recent diagnosis. 
 
Survivors who visited their medical specialist ≥4 times within the last 12 months 
(median split) were found to be more likely to have psychological distress. Visiting 
a medical specialist ≥4 times also was associated with a more recent diagnosis and 
reporting more comorbid conditions. In addition, survivors who visited their 
medical specialist ≥4 times were less likely to be diagnosed with Hodgkin 
lymphoma. 
 
Figure 2. Percentages of lymphoma and CLL survivors who reported to be psychologically 
distressed and percentages survivors who reported they received psychosocial care after 
treatment according to age categories. 
DISCUSSION 
 
Survivors of lymphoma and CLL contacted both a GP and medical specialist more 
frequently compared with an age-matched an sex-matched normative population 
without cancer, which is in keeping with our hypothesis. Survivors who reported 
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Table 2. ORs with 95% CIs of the multivariable logistic regression model evaluating 
psychosocial, sociodemographic, and clinical variables for receipt of psychosocial care after 
treatment and contact with GP and medical specialist within the last 12 months (median split). 
 
Receiving 
psychosocial care  
(N=282) 
Contacting the 




≥4 times  
(N=783) 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Psychological variables   
Psychological distress (yes)  2.19 (1.62-2.98) 2.06 (1.57-2.69) 1.80 (1.36-2.38) 
Sociodemographic variables   
Age 0.97 (0.96-0.98) 1.02 (1.01-1.02) 1.00 (0.99-1.01) 
Sex (female) 2.00 (1.51-2.65) 1.41 (1.12-1.78) 1.00 (0.78-1.26) 
Partner (yes) 1.19 (0.85-1.67) 0.83 (0.63-1.08) 1.16 (0.88-1.53) 
Education level    
Low 1.32 (0.93-1.88) 0.83 (0.63-1.11) 1.05 (0.78-1.42) 
Middle (ref.) - - - 
High  1.02 (0.70-1.47) 1.07 (0.80-1.44) 1.06 (0.78-1.43) 
Clinical variables   
Time since diagnosis 0.96 (0.91-1.02) 0.93 (0.89-0.98) 0.79 (0.75-0.83) 
Tumor type     
HL 0.93 (0.60-1.44) 1.16 (0.79-1.72) 0.67 (0.45-0.99) 
NHL-HG (ref) - - - 
NHL-LG 0.73 (0.50-1.07) 1.09 (0.80-1.50) 1.21 (0.88-1.68) 
CLL 0.43 (0.23-0.79) 0.83 (0.54-1.28) 0.97 (0.62-1.51) 
Treatment    
Active surveillance (yes) 0.99 (0.50-1.97) 1.31 (0.80-2.14) 1.36 (0.76-2.09) 
Systemic therapy (yes) 1.81 (1.00-3.27) 1.25 (0.80-1.50) 1.61 (1.03-2.54) 
Radiotherapy (yes) 0.84 (0.59-1.21) 0.91 (0.67-1.24) 0.97 (0.71-1.33) 
Comorbidities    
No comorbidities - - - 
1 comorbidity 0.89 (0.62-1.27) 1.14 (0.87-1.51) 1.27 (0.95-1.70) 
≥2 comorbidities 1.49 (1.03-2.15) 2.36 (1.73-3.21) 1.92 (1.40-2.65) 
Note. Bold type indicates statistical significance (P<.05). 
Abbreviations: 95% CI, 95% confidence interval; CLL, chronic lymphocytic leukemia; GP, general 
practitioner; HL, Hodgkin lymphoma; NHL-HG, high-grade non-Hodgkin lymphoma; NHL-LG, low-grade 
non-Hodgkin lymphoma; OR, odds ratio. 
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often. In addition to psychological distress, comorbidity, female sex and older age, 
were found to be associated with more frequent medical contacts, whereas 
younger age was associated with receiving psychosocial care. 
 
Previous findings of our group demonstrated that the frequency of contacts with 
both a GP and medical specialist was higher among long-term cancer survivors 
compared to a normative population [36]. These results also correspond with 
findings from studies among specific cancer groups that reported the more 
frequent use of health services for cancer survivors [37-40]. The difference between 
cancer survivors and the normative population in the number of contacts with a 
medical specialist persisted, even 10 years after diagnosis. However, the number of 
GP contacts normalized over time, which is in keeping with previous studies [36,39]. 
The higher number of contacts with a medical specialist observed among survivors 
of lymphoma and CLL can be explained by follow-up appointments as advised in 
the Dutch guidelines for the treatment of patients with lymphoma (available at: 
http://www.hovon.nl/).  
 
The current study findings that survivors who were psychologically distressed had 
more frequent medical contacts compared to non-distressed survivors correspond 
with previous results demonstrating that patients with cancer and psychological 
problems contacted a health care professional more frequently than patients 
without psychological problems [21,23,41]. Psychological problems that arise from 
or are aggravated by cancer might cause additional suffering resulting in more 
frequent medical contacts. Adequate recognition and treatment of psychological 
distress might help in reducing medical contacts among distressed survivors [18]. 
Psychosocial care should be considered to be an integral and standardized part of 
cancer care [42]. However, some healthcare professionals believe that psychosocial 
care is too costly to be part of standard cancer care [43], although to the best of 
our knowledge one study found that minimal psychosocial interventions may 
increase patient’s quality of life and reduce overall health care expenditures [43]. 
 
Many survivors are faced with psychosocial issues, and they may not receive the 
support they need. It is important to learn what support might benefit survivors of 
lymphoma and CLL [45]. The results of the current study demonstrated that 
patients who are psychologically distressed more often reported having received 
psychosocial care after treatment compared with non-distressed survivors, which 





and CLL received psychosocial care. Therefore, although information is lacking 
regarding the percentage of patients who refused psychosocial care when offered, 
potentially many more survivors could have benefitted from it. It is possible that 
survivors are unwilling to ask their GP or medical specialist for help with 
psychosocial concerns because they believe it is not the physician’s role to help 
with such problems [46]. Moreover, survivors may normalize or somatize their 
psychological distress, and consequently psychological distress may be 
underrecognized and undertreated [47]. Screening tools for psychological distress 
can be useful for its better recognition. In addition, providing feedback to survivors 
on their patient-reported outcomes can help them to monitor their functioning 
and symptoms and may help to empower them to discuss their symptoms with a 
GP or medical specialist [48].  
 
Because survivors with psychological distress may be unwilling to visit a mental 
health care professional, it is important to offer help in a way that is acceptable to 
them, without increasing the overall use of resources. In addition, the treatment of 
psychological distress has to be widely applicable, since the number of distressed 
survivors continues to grow [7].In the current study, approximately 22% of survivors 
of lymphoma and CLL reported that they received psychosocial care after 
treatment. This does not correspond with results of an American study by Hewitt 
and Rowland that reported that survivors of various cancer types contacted a 
mental health provider in only 7% of cases [49]. However, this could be due to 
different definitions. Hewitt and Rowland defined mental health care as talking to 
a psychiatrist, psychologist, psychiatric nurse, or social worker [49] In the current 
study, we also included oncology nurses as providers of psychosocial care because 
they appeared to be the ones who detect psychosocial concerns in patients [50]. 
Furthermore, previous studies have indicated that the use of psychosocial care 
services among cancer survivors was somewhat higher compared with in a 
population without cancer [49,51]. We could not relate these findings to the current 
study data because data regarding psychosocial care in the normative population 
were missing.  
 
According to the Andersen and Newman model of health services use [27], not 
only psychological distress is associated with the use of health care services, but 
also individual sociodemographic and clinical factors. In the current study, 
comorbidity and a more recent diagnosis were found to be associated with more 
medical contacts. This corresponds to the findings of a previous Dutch study that 
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also demonstrated a strong association between comorbidity and the volume and 
variety of health care services that are used [52]. It also was reported previously 
that the frequency of medical visits is highest within the first year after diagnosis 
[38,39].  
 
The use of psychosocial care services is greater among younger survivors, females, 
those with ≥2 comorbid conditions, and those who received systemic therapy. 
Raphael et al found that younger age was an indicator of increased distress [45], 
which might explain the greater use of psychosocial care services noted among 
younger survivors herein. Furthermore, the results of the current study correspond 
to those of a study that observed a greater use of psychosocial care services 
among younger survivors, those with more comorbid conditions, and those with 
psychological problems [49]. Another study also reported that older age was 
associated with lower likelihood of being referred for psychosocial care regardless 
of the level of psychological distress and provided some possible explanations [53]. 
It could be that physicians tend to perceive older survivors as less likely to need or 
to derive benefit from psychosocial care, or that physicians may underestimate the 
needs of older cancer survivors. More attention should be paid to older survivors 
with psychological problems because psychosocial care use in this group appears 
to be suboptimal.  
 
The current study has a few limitations. Although information was available 
regarding the sociodemographic and clinical variables of the non-respondents and 
patients with unverifiable addresses, it remains unknown why non-respondents 
declined to participate in the study. In addition, the cross-sectional design of the 
current study limited the determination of causal associations between the study 
variables. The strengths of the study are its population-based sampling frame, the 
high response rate, and the large range in time since diagnosis. This facilitates 
extrapolation of the results to a broad range of survivors of lymphoma. 
 
Survivors of lymphoma and CLL, especially those who report psychological distress, 
demonstrate an increased use of health care services compared with a normative 
population without cancer. Further studies are needed to explore whether the use 
of widely applicable psychosocial interventions could reduce the frequency of 
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Providing feedback to patients on their patient-reported outcomes (PROs) can help 
patients in monitoring their functioning and symptoms and may help empower them. 
The objective of this study was to investigate whether patients with lymphoma wished 
to receive PRO feedback, including the option to compare their scores with those of 
their peers, and how this feedback was evaluated. 
 
Methods 
We invited 64 patients participating in a lymphoma cohort who were eligible for a 
follow-up questionnaire and gave them the option to receive PRO feedback. Patients 
completed questions about health-related quality of life (HRQoL) and symptoms. PRO 
feedback was provided via bar charts. 
 
Results 
Of the 64 invited patients, 45 participated (response rate 70%) and 36 of those (80%) 
wished to receive PRO feedback. The vast majority (34/36, 94%) compared their scores 
with those of a lymphoma reference cohort, and 64% (23/36) compared their score 
with those of a normative population without cancer. All patients wished to receive 
feedback on their HRQoL, and 29 (81%) to 33 (92%) wanted feedback on their 
functioning, fatigue, neuropathy, anxiety, and depressive symptoms. Of the 36 
participants wishing to receive PRO feedback, 35 (97%) viewed it as being useful, with 
reassurance and knowledge about their own functioning in relation to what is “normal” 
being the most frequently mentioned reasons. 
 
Conclusions 
A high number of patients with lymphoma wished to receive PRO feedback. Patients 
reported the comparison of their scores versus a lymphoma reference cohort as most 
valuable. Further research should investigate whether PRO feedback could increase 








Patients with lymphoma are at risk of experiencing adverse physical and 
psychosocial effects of their cancer and its treatment such as fatigue, cognitive 
problems, anxiety and depression [1-4]. Management of these symptoms is often 
complex, and patients do not always know if their symptoms are common and are 
caused by their disease or treatment [5].  
 
Patient-reported outcomes (PROs) provide information about the subjective well-
being of patients [6]. PROs are standardized questionnaires that are completed 
by patients and measure a broad range of health related constructs including 
symptom assessment, and evaluation of function and health-related quality of life 
(HRQoL) [6,7]. Regular screening of physical and psychosocial symptoms by use 
of PROs could increase awareness and recognition of symptoms and can 
contribute to managing them [7-11]. PROs are furthermore useful in identifying 
issues that are most bothersome to patients [12] and can enable patients and their 
health professionals to jointly identify goals and priorities for future health and 
healthcare [13]. 
 
The use of PROs in clinical practice has increased in the past years [14]. Studies 
have shown that feedback from PROs can lead to improved symptom detection 
and more dialogue about problems between patients and physicians [7-11,15-19]. 
However, some studies reported no benefit from PRO feedback in the number of 
patients refererred to psychosocial care or in clinical actions taken [16,18,20,21]. In 
most of these studies, PRO feedback was provided to a health-care provider (e.g., 
a physician or nurse). A limitation of providing feedback to health-care providers 
might be that they may not always see the urgency of a specific problem and forget 
to discuss it. Some health-care providers were found to downgrade or miss 
symptoms such as fatigue and pain [22-24]. Physicians are furthermore most 
interested in PRO scores that indicate worsening symptoms, whereas patients 
prefer to see both worsened and improved scores [25]. The provision of PRO 
feedback to patients themselves might therefore be another and maybe better 
solution. Patients can then monitor all symptoms and initiate discussion on 
symptoms that bother them the most. Patients are moreover best placed to 
interpret their own subjective PROs within the complex context of their experience 
[26]. Patients also report that the inclusion of PROs in their clinical follow-up made 
them feel more in control of their care [27].  
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Comparison of a patients’ outcomes with those of patients with the same age and 
sex may help to reassure that what he or she is experiencing is “normal” or may 
empower the patient to take action. The aim of this study was therefore to 
investigate if patients with lymphoma wished to receive PRO feedback including 
the option to compare their scores with those of their peers. We furthermore 
investigated how patients evaluated the PRO feedback. We hypothesized that 
around two-third of patients would like to receive feedback, as research shows 




Participants and Setting 
This study was part of the Patient Reported Outcomes Following Initial treatment 
and Long term Evaluation of Survivorship (PROFILES) lymphoma registry [29]. This 
is a longitudinal population-based observational study whereby patients with 
Hodgkin lymphoma and non-Hodgkin lymphoma as diagnosed by the 
Netherlands Cancer Registry in 9 hospitals in the Netherlands complete 
questionnaires either on paper or online for research purposes. The first patients 
were included in 2009, and each year patient with a new diagnosis between 9 
months and 1.5 year after diagnosis are invited for questionnaire completion. 
Patients diagnosed less than 3 years ago are invited to complete a questionnaire 
every 6 months and patients diagnosed more than 3 years ago are invited to 
complete a questionnaire once a year. In January 2016, we invited patients with a 
diagnosis made less than 3 years previously and who were eligible for a follow-up 
questionnaire to participate in this study. Patients who participated online were 
given an option to receive PRO feedback.  
 
Questionnaire 
The questionnaire completed by patients consisted of the following: 
We used the Dutch validated version of the European Organisation for Research 
and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30) 
to assess HRQoL [30]. We added the symptom tingling in hands or feet, as it 
appeared from the literature and focus groups that this might be a prevalent 
symptom among patients with lymphoma. Answer categories range from 0 (not at 
all) to 3 (very much). After linear transformation, all scales and single item measures 





We used the Hospital Anxiety and Depression Scale (HADS) [31] to measure anxiety 
and depressive symptoms in separate subscales of 7 items each. Answers range 
from 0 to 3 and we calculated scores by addition of the items, with a higher score 
meaning more anxiety or depressive symptoms [31]. 
 
We also assessed patients’ marital status, educational level, and comorbidity in the 
questionnaire and categorized comorbidity at the time of survey according to the 
adapted Self-administered Comorbidity Questionnaire (SCQ) [32]. We obtained 
clinical characteristics (i.e., sex, age, type of lymphoma, date of diagnosis, stage at 
diagnosis, and primary treatment) from the Netherlands Cancer Registry. 
 
Procedure 
Eligible patients received a letter or email with an invitation to complete the 
questionnaire. Patients were informed that when they completed the questionnaire 
online they would have the possibility to receive PRO feedback. After completing 
the online questionnaire patients received the following question: “Would you like 
to receive feedback on your answers to the questionnaire?” If patients answered 
yes, we asked them on what topics they would like to receive feedback. They could 
choose from general quality of life, physical functioning, emotional functioning, 
cognitive functioning, social functioning, fatigue (based on their scores on the 
EORTC QLQ-C30), tingling hands or feet (based on their score on the question 
with respect to tingling hands or feet), anxiety or worries, and depressive symptoms 
(based on their scores on the HADS), or all topics. Subsequently, patients were 
asked whether they only wanted to see their own scores, and whether they would 
like to compare their scores with those of other patients with lymphoma or with 
those of people without cancer, or both. After that, the feedback was generated 
automatically by computer and was directly shown on the patients’ screens. If 
patients indicated that they did not wish to receive feedback, the feedback was not 
generated. Patients who viewed their PRO feedback received evaluation questions 
afterward. 
 
Patient-reported outcome feedback 
We based the content and layout of the PRO feedback on examples in the 
literature [33,34] and on lymphoma patients’ preferences reported in an earlier 
survey on how to provide PRO feedback. In this survey, we presented respondents 
with 2 examples of PRO feedback: in a bar chart and in a line chart. Respondents 
had a slight preference for the bar chart. Several examples of PRO feedback 
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presented as bar charts were subsequently evaluated by 12 persons (mean age 55 
years; 8/12, 67% female; 5/12, 42% low level of educational attainment). We asked 
them which colorway they preferred: traffic light colors, pastel colors, or PROFILES 
house-style colors. Here respondents preferred traffic light colors. Patients 
furthermore preferred a dotted line over a solid line to indicate “your score” in the 
bar chart. In this study, we therefore provided the PRO feedback via bar charts in 
traffic light colors with a dotted line to indicate a patient’s score. 
 
If patients wanted to view their own scores, a single bar chart was shown for each 
PRO feedback topic. If patients had indicated that they wanted to compare their 
scores with those of a lymphoma reference cohort or a normative population 
without cancer, both of the same sex and age, either 1 or 2 traffic light-colored bar 
charts were shown (see Figure 1 for an example).  
 
 
Figure 1. The example of cognitive functioning as part of patient-reported outcome 






Age was grouped into categories of 10-15 years, ranging from 18-30 years to older 
than 75 years. The colors of the bar charts were related to clinically relevant mean 
differences of the evidence-based guidelines of the EORTC QLQ-C30 [35]. A score 
that differed by less than the minimal medium clinically relevant difference from 
the mean score was considered average (amber). A score that differed as much or 
more than the minimal medium clinically relevant difference from the mean score 
was considered above average (green) or below average (red). We interpreted 
anxiety and depressive symptoms according to the published scoring algorithm 
with 0-7 indicating no or mild symptoms (green), 8-10 indicating moderate 
symptoms (amber), and ≥11 indicating severe symptoms (red) [31]. We added a 
detailed description of the meaning of the colors (traffic light model) and how to 
interpret the scores to assist patients in understanding the graphs (Textbox 1 shows 
cognitive functioning as an example). Patients with a symptom score in the red part 
of the bar chart were advised to contact their general practitioner. 
 
Textbox 1. Description of cognitive functioning (concentration and memory) as an example 
for interpreting the bar charts. 
Cognitive functioning is a component of quality of life. Cognitive functioning, for 
example, refers to the extent to which one can concentrate or can remember things. 
 
On the cognitive function component, you can score between 0 and 100. The higher 
the score, and the closer the score is to 100, the higher you will experience your quality 
of life in this part. Your score is shown in the graph by the purple line. 
 
Your score in comparison with other lymphoma survivors: 
• Your score falls in the yellow part. This indicates that your score is similar to that 
of other people with lymphoma with your age and sex. 
 
Your score in comparison with the general population: 
• Your score falls in the red part. This indicates that your score is lower than the 
average score of people from the general population with your age and sex. 
 
People with lymphoma score generally lower on cognitive functioning than the general 
population. Memory and concentration problems are common among people with 
cancer. Some also experience difficulty working under time pressure or doing different 
things at the same time. Others must make a greater mental effort to reach the same 
results compared with the period they were living without cancer [36]. 
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Lymphoma reference cohort and normative population 
We based the mean scores of the lymphoma reference cohort on data from our 
previous population-based study on HRQoL among 856 patients with lymphoma37. 
We extracted the mean scores of an age- and sex-matched normative population 
of 1859 individuals without cancer from a reference cohort from the general Dutch 
population (CentERpanel) [38].  
 
Evaluation questions 
The evaluation questions consisted of 5 open questions with respect to the 
usefulness, accessibility, clarity, and missing features of the feedback. Patients were 
furthermore asked whether they would have liked to see different features in the 
PRO feedback. Based on the average scores on HRQoL and anxiety and depressive 
symptoms, we evaluated whether both patients with or patients without symptoms 
wanted to receive PRO feedback. 
 
Statistical analysis 
Analyses were performed using SAS version 9.1 (SAS Institute Inc., Cary, North 
Carolina). P<.05 were considered statistically significant. We determined clinically 
relevant differences using the evidence-based guidelines of the EORTC QLQ-C30 
[35]. We used Fischer exact tests or t-tests to compare differences in 
sociodemographic and clinical characteristics between respondents and 
nonrespondents and between patients who wished and those who did not wish to 
receive PRO feedback. 
 
To evaluate whether scores were on average comparable with those of a 
lymphoma reference cohort, we compared patients’ mean EORTC QLQ-C30 and 
HADS scores with mean scores of a lymphoma reference group using analysis of 
covariance with age and sex as covariates. We also compared patients’ mean 
scores, in the same way, to those of a normative population. The numbers of 
patients scoring in the red, amber or green part were computed to evaluate 










Of the 64 patients who were invited, 45 participated (response rate 70%). Their 
mean age was 60.7 years and 58% (N=26) were male. Mean time since diagnosis 
was 2.8 years, and 82% (N=37) had a diagnosis of non-Hodgkin lymphoma. Most 
patients underwent systemic therapy or radiotherapy, or both. Sociodemographic 
and clinical characteristics did not statistically differ between respondents and non-
respondents (Table 1). 
 
Evaluation of patient-reported outcome feedback 
A total of 36 (80%) participants wished to receive PRO feedback, with similar 
percentages for males and females (21/26, 81% vs 15/19, 79%; P=.29) and for 
patients under and above 65 years of age (20/26, 77% vs 16/19, 84%; P=.25). 
Patients who wished to receive PRO feedback had scores on overall HRQoL (P=.14) 
and anxiety (P=.47) and depressive symptoms (P=.25) similar to those of patients 
who did not wish to receive feedback. 
 
The vast majority (34/36, 94%) compared their scores with those of the lymphoma 
reference cohort and 64% (23/36) compared their scores with those of the 
normative population without cancer, whereas 6% (2/36) viewed only their own 
scores. All patients viewed the PRO feedback on their overall HRQoL, and 81% to 
92% viewed feedback on their physical, emotional, social, and cognitive 
functioning, fatigue, tingling in hands or feet, anxiety, and depressive symptoms 
(Table 2). 
 
Almost all patients (except 1) viewed the PRO feedback as being useful, with 
reassurance and knowledge about their own functioning in relation to what is 
“normal” being the most frequently mentioned reasons. The option to compare 
their scores with those of a lymphoma reference cohort of the same age and sex 
was reported as most valuable: 
 
“This score shows what I actually did expect of my quality of life. The comparison with 
other patients with lymphoma feels right. I mean, I do not score that different and that 















 n(%) n(%) P 
Sociodemographic characteristics    
Sex   .27 
Male 26 (58) 14 (74)  
Female 19 (42) 5 (26)  
Age: mean (SD) 60.7 (13.6) 63.8 (14.7) .28 
<65  26 (58) 8 (42)  
≥65  19 (42) 11 (58)  
Marital status    
Partner 34 (76) N/A  
No partner 11 (24) N/A  
Education    
Secondary 8 (18) N/A  
Intermediate vocational 17 (38) N/A  
High vocational or university 20 (44) N/A  
Clinical characteristics     
Type of lymphoma   .26 
Hodgkin 8 (18) 1 (5)  
Non-Hodgkin 37 (82) 18 (95)  
Years since diagnosis (mean SD) 2.8 (0.8) 2.6 (0.7) .84 
Cancer stage at diagnosis   .50 
I 8 (22) 4 (29)  
II 10 (28) 2 (14)  
III 5 (14) 4 (29)  
IV 13 (36) 4 (29)  
Primary treatment   .11 
Radiotherapy only 2 (4) 1 (5)  
Systemic therapy (e.g., chemotherapy, 
immunotherapy) 19 (42) 8 (42)  
Systemic therapy plus radiotherapy 13 (29) 1 (5)  
Active surveillance 11 (25) 9 (47)  
Self-reported comorbidities: mean (SD) 1.3 (1.3) N/A  
Most frequent comorbidities  
Arthritis 10 (22) N/A  
Heart problems 8 (18) N/A  
High blood pressure 8 (18) N/A  
Note..  N/A: not available. 





Table 2. Overview of PRO feedback topics with number and percentage of interested 
patients. 
Topic n % 
EORTC QLQ-C30   
General health-related quality of life 36 100 
Physical functioning 33 92 
Emotional functioning 32 89 
Social functioning 33 92 
Cognitive functioning 31 86 
Fatigue 31 86 
Neuropathy 29 81 
HADS   
Anxiety 30 83 
Depressive symptoms 30 83 
Abbreviations: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality 
of Life Questionnaire Core 30; HADS, Hospital Anxiety and Depression Scale. 
 
“It is interesting to see how I stand compared to other patients with lymphoma and the 
general population.” - Male patient with Hodgkin lymphoma, 22 years old 
 
“The PRO feedback clarifies if symptoms are shared by others or not.” - Female patient 
with Hodgkin lymphoma, 37 years old 
 
Some patients reported that the PRO feedback was useful, since it provided new 
insights for discussion with their physician. No reason was provided by the patient 
who indicated that the PRO feedback was not useful. 
 
A total of 2 patients reported that the PRO feedback had missing features; 1 patient 
advised us to provide more information on how to limit symptom burden or 
improve symptoms; and 1 patient suggested that it would be good to advise 
patients to go to their general practitioner when experiencing problems: 
 
“Not everyone has good and regular contact with their doctors, so it would be helpful to 
advise a patient to contact a doctor when he or she reports problems.” - Female patient 
with non-Hodgkin lymphoma, 54 years old 
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The comment regarding contacting a general practitioner was already covered for 
the symptoms in the current PRO feedback for patients scoring in the red part of 
the bar chart, but not for the functioning scales. 
 
With respect to the clarity of the PRO feedback, 1 patient missed the possibility to 
go back to his answers in the questionnaire to verify that the PRO feedback was 
correct, because his score on neuropathy was very low according to the PRO 
feedback, but not in his experience. Furthermore, 1 patient had trouble 
understanding the colors of the PRO feedback at first, but after looking for a 
second time it became clear. With respect to things that should be different, some 
patients indicated that they wished to save their scores for future comparison 
purposes and to keep track of their scores: 
 
“Is it possible to download my PRO feedback, so I can compare my scores over time 
and determine potential deterioration?” - Male patient with non-Hodgkin 
lymphoma, 84 years old 
 
Health-related quality of life, anxiety, and depression scores 
Mean scores on HRQoL, anxiety, and depressive symptoms of participating 
patients in this study were not different from the mean scores of the lymphoma 
reference cohort (Table 3). Compared with the normative population, patients had 
on average statistically and clinically relevant lower scores on physical, cognitive, 
and social functioning and higher scores on fatigue (all P<.05). 
 
With respect to patients’ individual scores on HRQoL, 33% (N=15) of patients 
reported scores that were lower than the average of the lymphoma reference 
cohort (red part of bar chart) and 31% (N=14) reported scores higher than the 
average range of scores (green part of bar chart; Table 4). Compared with the 
normative population, 33% (N=15) of patients reported scores that were lower than 
the average and 20% (N=9) reported scores higher than the average of the 





Of the participating patients with lymphoma, 80% wished to receive PRO feedback, 

































































































































































































































































































































































































































































































































































































































































Table 4.  Number and percentages of patients scoring lower than average, average, or 
higher than average compared with the lymphoma reference cohort and normative 








Lower than average (red) 15 (33) 15 (33) 
Average (amber) 16 (36) 21 (47) 
Higher than average (green) 14 (31) 9 (20) 
Abbreviations: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality 
of Life Questionnaire Core 30 
 
 
percentage of men and women and patients younger and older than 65 years 
wished to receive PRO feedback. They reported the comparison of their scores 
with those of a lymphoma reference cohort as being very valuable, since it 
provided information about their functioning in relation to what is “normal”. 
 
An advantage of providing PRO feedback to patients themselves is that patients 
can monitor their symptoms at any specific point in time. Patients are furthermore 
provided with information that they can use to actively engage with their physician 
when discussing symptoms [26,27]. However, not all patients will be self-assertive 
enough to bring up their problems and, in that case, providing feedback to both 
patients and physicians, as is done in some studies [16-18], might be more effective 
for discussing problems and taking action with respect to referral to other health 
care professionals. Almost all patients indicated that the PRO feedback was useful 
and reassuring. Even when patients had scores that were below average, they still 
viewed PRO feedback as useful. The latter pleads for providing PRO feedback as a 
standard option in care. However, before PRO feedback is provided, patients need 
to be asked for their preference, as still 20% indicated that they did not want to 
receive PRO feedback. This is the case for information provision in general, as 
patients fare psychologically, behaviorally, and physiologically better when the 
information they receive about their medical condition is tailored to their coping 
styles, whereby those with a monitoring style tend to do better when given more 
information, and those with a blunting style do better with less information [39]. 
 
Since the feedback was generated automatically after patients completed the 





addition, providing PRO feedback is valuable for other research that is performed 
with online questionnaires, as well as for patients with other medical conditions in 
terms of empowering patients and monitoring their functioning and symptoms. 
 
In this study, we evaluated PRO feedback in a research setting at a fixed time point, 
but this kind of PRO feedback could also be of merit for patients at any given point 
in time outside of a research setting. It can, for example, be used as a tool for 
keeping track of their scores, which may help patients to feel more in control of 
their cancer and care [27]. 
 
Limitations  
The sample size was relatively small, although we obtained a response rate of 70%. 
The PRO feedback was accessible only to patients completing the questionnaire 
online, which limits the generalizability of the results to the total lymphoma 
population, as patient characteristics are different for patients who participated 
online versus patients who participated on paper [40]. 
 
Conclusion 
Future research should determine whether this kind of feedback could also 
increase empowerment and possibly improve HRQoL. 
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Patients with lymphoma are at risk of experiencing adverse physical and psychosocial 
problems of their cancer and its treatment. Regular screening of these symptoms by 
use of patient reported outcomes (PROs) could increase timely recognition and 
adequate symptom management. Moreover, self-management interventions intend to 
enhance knowledge and skills and empower patients to better manage their disease 
and related problems. The objective of the Lymphoma InterVEntion (LIVE) trial is to 
examine whether feedback to patients on their PROs and access to a web-based self-
management intervention named Living with lymphoma will increase self-management 
skills and satisfaction with information, and reduce psychological distress. 
 
Methods 
The LIVE randomized controlled trial consists of three arms: 1) standard care, 2) PRO 
feedback, and 3) PRO feedback and the Living with lymphoma intervention. Patients 
who have been diagnosed with Hodgkin lymphoma, non-Hodgkin lymphoma, 
including chronic lymphocytic leukemia as registered in the Netherlands Cancer Registry 
in various hospitals will be selected for participation. Patients are invited via their 
haemato-oncologist 6 to 15 months after diagnosis. The PRO feedback includes a 
graphical overview of patients’ own symptom and functioning scores and an option to 
compare their scores with other patients with lymphoma and a normative population 
of the same age and sex. The Living with lymphoma intervention is based on cognitive-
behavioral therapy components and includes information, assignments, assessments, 
and videos. Changes in outcomes from baseline to 16 weeks, 12 and 24 months post-
intervention will be measured. Primary outcomes are self-management skills, 
satisfaction with information, and psychological distress. Secondary outcomes are 
health-related quality of life, illness perceptions, fatigue, and health care use.  
 
Discussion 
The results of the LIVE trial will provide novel insights in whether access to PRO feedback 
and the Living with lymphoma intervention will be effective in increasing self-
management skills and satisfaction with information, and reducing distress. The LIVE 
trial is embedded in a population-based registry, which provides a unique setting to 
ascertain information on response, uptake and characteristics of patients with 
lymphoma in web-based intervention(s). When effective, PRO feedback and Living with 









Due to advances in treatment, the 20-year prevalence of Hodgkin lymphoma (HL) 
and non-Hodgkin lymphoma (NHL) in the Netherlands is expected to increase by 
5% to 6300 and 32,000 patients in 2020, respectively [1,2]. As a result of their cancer 
and its treatment, patients with lymphoma are at risk of experiencing adverse 
physical and psychosocial problems, such as fatigue, neuropathy, cognitive and 
emotional problems [3-6]. Patients who report adverse problems have a lower 
health-related quality of life (HRQoL) and visit their physician more often [7-9]. In 
addition, up to a quarter of patients with lymphoma experience persistent levels of 
anxiety, depressive feelings and fears, also called psychological distress [7-10].  
 
Patient-reported outcomes (PROs) intend to evaluate the impact of a disease and 
its treatment from the perspective of the patient [11]. PROs are being increasingly 
recognized to be important in daily practice [12-13]. Regular screening of physical 
and psychosocial symptoms by use of PROs could increase awareness and 
recognition of symptoms and can contribute to adequate symptom management 
[11,14-17]. Moreover, the greater the resources available for coping with symptoms 
and stress, the lower the risk for psychological distress [18]. Interventions using 
cognitive behavioral therapy (CBT) components, such as psychoeducation and 
coping skills, can reduce persistent psychological distress and physical problems 
and improve HRQoL [8]. 
 
As the number of patients surviving lymphoma continues to grow, interventions 
need to be easily accessible and without increasing the burden on health services. 
Self-management interventions can be effective in strengthening the role of 
patients, by increasing patient engagement in care, and limit the burden on health 
services [19,20]. Self-management interventions aim to empower patients to have 
an active role in the management of their disease and its symptoms and 
consequences, including treatment, physical, psychosocial and lifestyle changes 
[21,22]. Web-based technologies are particularly suitable for self-management 
interventions, since they are easily accessible, can reach a large number of patients 
[19,23], and provide more anonymity compared to face-to-face interventions [24], 
Therefore, web-based interventions have the potential to eliminate barriers to 
psychosocial care for patients with cancer. However, it is important that such 








The Lymphoma InterVEntion (LIVE) trial consists of two interventions: 1) feedback 
to patients on their PROs, and 2) a web-based self-management intervention 
named Living with lymphoma. Patients will be randomized to: 1) standard care, 2) 
standard care plus access to PRO feedback, or 3) standard care plus access to PRO 
feedback and the Living with lymphoma intervention. PRO feedback enables 
patients to monitor their symptoms and compare them with outcomes among 
other patients. This may help to either reassure that what they experience is 
‘normal’ or may empower them to take action. The Living with lymphoma 
intervention is based on CBT components and is an adaptation from the evidence-
based BREAst cancer e-healTH (BREATH) intervention [26]. By using the Living with 
lymphoma intervention, patients will receive psychoeducation and learn coping 
skills, which they can apply as self-management skills in daily life.  
METHODS AND DESIGN 
 
Objectives and hypotheses 
The objective of the LIVE trial is to examine whether PRO feedback and the Living 
with lymphoma intervention will increase self-management skills and satisfaction 
with information and reduce psychological distress. In concordance with the stress-
coping model of Lazarus and Folkman (1984), psychological adjustment after 
cancer is determined by the balance between stress and resources [18]. Therefore, 
it is hypothesized that patients with access to PRO feedback and/or the Living with 
lymphoma intervention will report increased self-management skills and 
satisfaction with information (greater resources available for coping), and lower 
levels of psychological distress compared to patients receiving standard care. 
Moreover, it is expected that patients with access to both PRO feedback and the 
Living with lymphoma intervention will benefit most.. 
 
Study design 
The LIVE-trial is designed as a non-blinded randomized controlled trial with three 
arms. For an overview of the design of the trial, see Figure 1. Standard care plus 
the access to PRO feedback and the Living with lymphoma intervention (arm 3) will 
be compared to standard care plus access to PRO feedback (arm 2) and standard 
care (arm 1). Patients with lymphoma from various hospitals in the Netherlands will 
be included and asked to complete questionnaires at four points in time: baseline 
(T0; 6 to 15 months after diagnosis), after 16 weeks (T1; post-intervention), after 12 







Figure 1. Overall study design of the Lymphoma InterVEntion (LIVE) trial 
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Study population  
All patients who have been diagnosed with HL or NHL, including chronic 
lymphocytic leukemia (CLL) as defined by the International Classification of 
diseases for Oncology-3 codes (ICD-O-3) [27], in the participating hospitals will be 
selected for participation via the Netherlands Cancer Registry (NCR). Patients must 
be aged 18 years or older at time of diagnosis. Patients who have problems with 
the Dutch language, patients with severe psychopathology or dementia, and 
patients in transition to terminal care will be excluded from the study. 
 
Setting 
LIVE-trial will be conducted within the Patient Reported Outcomes Following Initial 
treatment and Long term Evaluation of Survivorship (PROFILES) registry [28]. 
PROFILES is a tool that enables data collection management; from inviting patients 
to participation in studies, to collecting PRO data via web-based or mailed 
questionnaires and linking these data with clinical data. Since this trial is embedded 
in the population-based PROFILES lymphoma registry, we have access to 
information on response, uptake and user characteristics of patients with 
lymphoma in a web-based intervention. 
 
Recruitment 
The population-based NCR of the Netherlands Comprehensive Cancer 
Organisation (IKNL) will be used to select all patients in the participating hospitals 
who meet the inclusion criteria. The NCR registers all newly diagnosed cancer 
patients within six months after diagnosis. After excluding deceased patients, the 
treating haemato-oncologists are asked to verify the patients’ study eligibility. All 
eligible patients will be invited for participation by their own haemato-oncologist. 
The haemato-oncologists will provide the eligible patients with an invitation 
package, including an invitation letter and leaflet to inform them about the study, 
a postcard, and two informed consent forms (i.e., one for the researchers and one 
for the patient). The letter explains the study objectives and includes a link and 
password to a secure website, so that patients can complete questionnaires online. 
If patients prefer paper-and-pencil participation, they can complete the postcard 
and return it by mail to the study manager. Patients will then receive paper-and-
pencil questionnaires and a pre-stamped envelope within one week of receipt of 
the postcard. Patients are informed that paper-and-pencil participation 
automatically means that they will not be able to participate in the LIVE-trial and 





feedback and the Living with lymphoma intervention are web-based. If the 
questionnaire is not completed within three weeks, a reminder will be sent by the 
treating haemato-oncologists. After obtaining informed consent, the subsequent 
communication to the patients will be addressed via PROFILES. To guarantee 
anonymity, questionnaires only contain a study number.  
 
Randomization  
Patients who complete the baseline questionnaire online and consent to 
participate in the LIVE-trial, will be automatically randomized in an equal ratio (1:1:1) 
to one of the three study arms: 1) standard care, 2) standard care plus access to 
PRO feedback, or 3) standard care plus access to PRO feedback and the Living with 
lymphoma intervention. This randomization will be performed using block 
randomization. The randomization will be performed by a computer 
randomization program, which will ensure a balance in sample size across groups 
over time [29].  
 
Interventions versus standard care 
Arm 1: Standard care 
For patients randomized to arm 1, the haemato-oncologist provides standard care. 
Most haemato-oncologists give their patients leaflets regarding the diagnosis and 
treatment they receive. Most information is given during the initial treatment 
phase, and some of the haemato-oncologists give additional information during 
follow-up, for ad-hoc referrals if needed by the patient. Patients who receive 
standard care can use information about lymphoma on the internet, but do not 
have access to PRO feedback or the Living with lymphoma intervention.  
Arm 2: PRO feedback  
Patients randomized to arm 2 and 3 have access to PRO feedback, including 
general HRQoL, physical, emotional, cognitive and social functioning, fatigue, 
neuropathy (only for patients with high-grade NHL), anxiety and depressive 
symptoms. Patients can compare their scores to mean scores of other patients with 
lymphoma (same sex and age group) and/or a normative population (same sex 
and age group) to find out whether their scores are average or not (using a traffic 
light model). A detailed description of how to interpret the scores is added to assist 
patients in understanding the graphs. Mean scores of the lymphoma sample are 
extracted from data of our previous research on HRQoL among 856 patients with 







1859 individuals from the general Dutch population (CentERpanel). This cohort is 
representative for the Dutch-speaking population in the Netherlands [31]. 
Individual scores will be integrated into graphical displays with colored bar-charts 
[32,33]. The colors of the bar-charts are related to clinically relevant mean 
differences of the evidence-based guidelines of the EORTC QLQ-C30 [34]. A score 
that differs less than the minimal medium clinically relevant difference from the 
mean score is considered ‘average’ (amber). A score that differs as much as or 
more than the minimal medium clinically relevant difference from the mean score 
is considered ‘above average’ (green) or ‘below average’ (red). The interpretation 
of anxiety and depressive symptoms is according to the published scoring 
algorithm: 0-7 indicating no or mild symptoms (green), 8-10 indicating moderate 
symptoms (amber), and ≥11 indicating severe symptoms (red) [35]. Patients with a 
score in the red part of the chart are advised to contact their general practitioner. 
For an example of PRO feedback, see Figure 2.  
 
 






To review the PRO feedback, patients have to click on the ‘feedback’ tab after 
completing the questionnaire. Patients can decide not to review their PRO 
feedback as they prefer not to.  
Arm 3: PRO feedback + ‘Living with lymphoma’ intervention 
In addition to PRO feedback, patients randomized to arm 3 get access to the Living 
with lymphoma intervention. This web-based self-management intervention is an 
adaptation of the evidence based BREATH intervention for breast cancer survivors 
[26,26]. The content of the intervention is adapted to warrant its relevance for 
patients with lymphoma. Symptoms that are typically common in patients with 
lymphoma, such as neuropathy, infections and infertility, have been added. 
 
One key feature of the intervention is the ‘work space’ that includes four phases: 1) 
‘looking back’, 2) ‘emotional processing’, 3) ‘strengthening’, and 4) ‘looking ahead’. 
For a screenshot of the ‘work space’, see Figure 3. The intervention is based on 
CBT techniques, such as psychoeducation, to enhance patients’ knowledge and 
skills, for instance by providing tailored advices based on patients’ input. Working 
ingredients of the four phases include information, assignments, assessments, and 
videos. The information part provides patients with knowledge on various subjects, 
such as adverse physical and psychological problems, work, sexuality, and lifestyle. 
Assignments are for example writing tasks, social engagement or conversation 
tasks and aim to increase skill-building [26]. Assessments include tests that could 
be used by patients as a screening instrument of potential problems and are 
followed by automated feedback. Videos are clips extracted from recorded 
interviews with patients with lymphoma. Another feature of the intervention is the 
library with background and additional information on subjects from the four 
phases (e.g., work, sexuality, lifestyle). For a screenshot of the library, see Figure 4. 
The library also contains links to additional health care services (e.g., psychologists, 
physiotherapists, dieticians).  
 
The advised intervention usage is one part per week, with a duration of 
approximately one hour. However, it is up to the patients how and to what extent 
they use the intervention. From the BREATH intervention it is known that patients 
use the website quite diverse [37]. The intervention is fully-automated and non-
guided and is delivered without professional support of a therapist. Support for 









Figure 3. Screenshot from the ‘work space’ of the Living with lymphoma intervention with 
phase structure (in Dutch). 
 
 





Study outcomes measures 
Patient demographics and clinical information will be available from the NCR that 
routinely collects data on among other things patients’ age and sex, date of cancer 
diagnosis, histological classification, stage, treatment and comorbidity. Information 
on marital status, educational level, and employment status are gathered by self-
report using questionnaires. 
Primary outcomes 
Self-management skills are measured by the Health Education Impact 
Questionnaire (heiQ) [38]. The heiQ contains 40 items across eight scales: positive 
and active engagement in life, health-directed activities, skill and technique 
acquisition, constructive attitudes and approaches, self-monitoring and insight, 
health service navigation, social integration and support, and emotional distress. 
Each item will be scored on a four-point Likert-scale. The scale scores are obtained 
by computing the mean of respective items. Higher scores indicate better status 
or self-management, except for emotional distress, in which higher scores indicate 
higher distress [38]. The heiQ has high construct validity [38]. Five scales of the 
heiQ are validated among patients with cancer [39].  
 
Psychological distress will be assessed by the 14-item Hospital Anxiety and 
Depression Scale (HADS) [35]. A sum score is obtained by adding the items. Its 
rating system is based on a four-point format and asks how the patient has felt in 
the past week. Higher scores indicate higher levels of psychological distress. The 
HADS has shown good reliability and validity in oncology settings [40,41]. 
 
Satisfaction with information will be measured by an adapted version of the 9-item 
Information Satisfaction Questionnaire (ISQ) [42]. The ISQ has been widely used to 
assess overall information satisfaction and the need for involvement in decision 
making. The original measure demands patients to categorize themselves into one 
of three groups: those who would like 1) all available information and to be involved 
in decisions about the illness; 2) only positive information about the illness; and 3) 
only limited information and prefer the doctor to make the decisions. However, 
Fallowfield suggests that there is a distinction between the desire for information 
and involvement in decision making [43]. Therefore, we divided that question in 
two items, one assessing the desire for information and one assessing the desire 
for involvement in decision making. Patients are furthermore asked to rate their 
level of satisfaction with the information they have received about their illness, 







scale. The English version of the ISQ was translated into Dutch by forward-
backward translation procedures. Questions about desire for more or less 
information, helpfulness of information, and the use of internet (to search for 
information) were added to the questionnaire. 
Secondary outcomes 
Health-related quality of life―general will be assessed using the Dutch validated 
European Organisation for Research and Treatment of Cancer (EORTC) Quality of 
Life Questionnaire (QLQ-C30) [44]. This 30-item questionnaire includes 5 
functional scales, 3 symptom scales, a global health and quality of life scale, and 
several single-item symptom measures. All items will be scored on a 4-point Likert 
scale, except for the global health and quality of life scale that is scored on a 7-
point linear analogue scale. After linear transformation, all scales and single item 
measures range in score from 0-100. Higher scores on functional and health and 
quality of life scales indicate better functioning or HRQoL, whereas higher scores 
on symptom scales indicate more complaints.  
 
Health-related quality of life―lymphoma specific will be assessed with the EORTC 
disease specific modules, i.e. QLQ-HL27 for HL, QLQ-NHL-HG29 for high-grade 
and QLQ-NHL-LG20 for low-grade NHL, and QLQ-CLL17 for CLL [45]. The 
modules are divided in multi-item subscales including symptom burden, physical 
condition/fatigue, worries/fears, health and functioning, emotional impact, and 
neuropathy (only in the NHL-HG29 module). Items are scored on a 4-point Likert 
scale. After linear transformation, all scales range in score from 0-100, whereby a 
higher score reflects more problems [45]. 
 
Self-efficacy with regard to symptoms (in this study as a result of lymphoma) will 
be measured with the self-efficacy scale (SE28) [46-48]. This scale consists of seven 
items, which will be scored on a four-point Likert scale. A higher score reflects more 
sense of control. This scale had previously been used to assess self-efficacy 
concerning post-cancer fatigue [49]. 
 
Adjustment to cancer will be assessed using the 40-item Mental Adjustment to 
Cancer Scale (MAC) [50]. Items are rated on a four-point Likert scale. The summary 
scales (i.e., summary positive adjustment scale, summary negative adjustment 
scale) can be used to identify general adjustment styles for cancer. The summary 
positive adjustment scale includes 17 items and scores range from 17-68 (cut-off 





scores ranging from 16-64 (cut-off ≥36) [51]. Summary scales are scored through 
addition of the items.  
 
Illness perceptions will be assessed using the validated Brief Illness Perception 
Questionnaire (BIPQ) [52]. This scale has 9 items, measuring cognitive 
representations, emotional representations, and illness comprehensibility. Items 
are scored on a continuous linear 0-10 point scale. A higher score reflects a more 
threatening view of the illness. The BIPQ has previously cross-culturally adapted 
into the Dutch Language Version (Brief IPQ-DLV), with acceptable face and content 
validity [53].  
 
Fatigue will be assessed with the 20-item validated Multidimensional Fatigue 
Inventory (MFI) [54]. The MFI covers five scales: general fatigue, physical fatigue, 
reduced activity, reduced motivation, and mental fatigue. Each scale contains 4 
items, with 2 items formulated in a positive (e.g., I feel fit) and 2 formulated in a 
negative direction (e.g., I feel fatigued). All items are scored on a 5-point Likert 
scale. The negative formulated items must be recoded before adding up scores. 
Higher sum scores correspond with more acute levels of fatigue. The MFI is reliable 
and valid to assess fatigue in patients with cancer [54].  
 
Health care use will be assessed by single-items: ‘How often did you contact a 
general practitioner in the past 12 months?’, ‘How many of these visits were related 
to cancer of the consequences of your cancer?’, ‘How often did you visit a medical 
specialist in the past 12 months?’, ‘How many of these visits were related to cancer 
or the consequences of your cancer?’. These questions were asked in a similar way 
as by Statistics Netherland [55] (http://statline.cbs.nl/). Three questions are asked 
about follow-up appointments (whether or not receiving follow-up appointment, 
the frequency of follow-up appointments and satisfaction with this frequency). 
Furthermore, patients are asked whether they visited a psychologist, psychiatrist or 
social worker and the last question was ‘Did you receive care after the treatment 
of your cancer?’ To answer this question, patients could either choose ‘No’ or ‘Yes’ 
and then choose multiple additional care services from a list: sexologist, pastoral 
care, dietician, physical therapist, oncological rehabilitation, creative therapy, 











Comorbidity at the time of survey will be assessed with the adapted Self-
administered Comorbidity Questionnaire (SCQ) [56]. Patients will be asked to 
identify comorbid conditions developed since diagnosis.  
 
Personality will be assessed using the Big Five Inventory (BFI) [57]. The BFI is a 44-
item inventory designed to measure the Big Five dimensions: extraversion, 
agreeableness, conscientiousness, neuroticism and openness to experience. Items 
are scored on a 5-point Likert scale. Scale scores will be created by averaging the 
items for each domain. The Dutch BFI has good psychometric quality [58]. 
Usage statistics 
In addition to the standardized questionnaires, technical data on the use of the 
intervention, such as frequency, duration and activity, will be evaluated.  
 
Sample size calculation 
Sample size calculation was performed using G*Power version 3.1.9.2 for Windows. 
Based on the three primary outcomes of this trial, effect on patient level is defined 
as increased self-management skills or satisfaction with information (as measured 
by the heiQ and the ISQ, respectively) or reduced psychological distress (as 
measured with the HADS). Therefore, effectiveness of LIVE is demonstrated when 
one of the three effects is statistically significant. Significance level of the sample 
size calculation was adjusted to P ≤.167 to keep the overall chance for type-I errors 
at 5%.  
 
Clinically important differences will be determined with Norman’s ‘rule of thumb’, 
whereby a difference of ≈0,5 SD indicates a threshold of discriminant change in 
quality of life scores of a chronic illness [59]. To detect a clinically important 
difference with 90% power, a sample size of 222 patients with lymphoma (74 in 
each group) is needed. This sample size calculation is based on a medium effect 
size of 0.25 for repeated measures ANOVA with two measurements, since at least 
two measurements are necessary to compare pre-intervention and post-
intervention outcomes. We take into account a response rate of 70% as observed 
in earlier studies (of them 60% is expected to complete the questionnaires online) 
and a study drop-out rate of 25%, based on a systematic review on adherence in 
internet interventions for anxiety and depression [60]. This results in 663 patients 







All statistical analyses will be performed using Statistical Analyses Software (SAS; 
version 9.4 for Windows, SAS Institute Inc., Cary NC, USA). Analyses on 
effectiveness of the intervention will be primarily done according to intention-to-
treat methodology. Second, per protocol analysis will be performed to analyze the 
efficacy of the intervention. All statistical tests will be two-sided and considered 
significant if P <.05.  
 
Missing outcome data will be assumed to be 'missing at random' (MAR), 
conditional on key predictors of 'missingness' (in particular baseline values of the 
outcome variables of interest, and study arm).  
 
Patients’ sociodemographic and clinical variables will be compared at baseline 
between the three study arms using chi-square analyses for categorical variables 
and ANOVA for continuous variables and will be analyzed as covariates.  
 
Repeated measures analysis using generalized estimating equations, which 
account for the intra-patient dependency of the repeated measures, will be used 
to analyze the effect of the intervention on the outcome variables. We will 
investigate differences in effect of the two intervention arms and the arm receiving 
standard care at the different time points. Differential effects of the intervention 
arms by age, cancer subtype and baseline levels of the outcomes of interest will 
be assessed for the outcome measures by adding terms for the interaction 
between age, cancer subtype, baseline levels and care arm to the regression 
models.  
 
Routinely collected data from the population-based NCR on patient and tumor 
characteristics will enable us to compare paper-and-pencil respondents with online 
respondents, as well as respondents with non-respondents and patients with 
unverifiable addresses in order to determine the external validity of the results and 
answer our second study objective.  
DISCUSSION 
 
Regular screening of symptoms by use of PROs and access to resources for coping 
skills could help to detect and/or manage symptoms that up to a quarter of 







novel insights in whether access to PRO feedback and the Living with lymphoma 
intervention will be effective in increasing self-management skills and satisfaction 
with information, and reducing psychological distress. Since one-third of patients 
will be randomized to solely access to PRO feedback and not to the Living with 
lymphoma intervention, it will be possible to investigate the superiority of access 
to PRO feedback as well as the superiority of access to PRO feedback and the 
Living with lymphoma intervention compared to standard care.  
 
The LIVE-trial is embedded in the population-based PROFILES lymphoma registry, 
which provides a unique setting to ascertain information on response, uptake and 
characteristics of patients with lymphoma in web-based intervention(s). This 
information is important with respect to the generalizability of results and 
moreover, it demonstrates which patients subgroups will benefit most from PRO 
feedback and the Living with lymphoma intervention. Patients will not be selected 
based on their symptoms or distress level prior to study entry and it is up to patients 
themselves how and to what extent they use the intervention(s). When effective, 
access to PRO feedback and the Living with lymphoma intervention could serve as 
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Based on patients’ wishes to get insight in their own patient-reported outcomes (PRO) 
data, the Lymphoma InterVEntion [LIVE] trial was conducted to examine the effects of 
PRO feedback to patients and a web-based self-management intervention – Living with 
lymphoma – on psychological distress, self-management, satisfaction with information, 
and healthcare use in population-based setting.  
 
Methods 
PRO feedback included comparison with age- and sex-matched peers and was built in 
the PROFILES registry. Living with lymphoma was an adaptation of an evidence-based 
intervention for breast cancer survivors. Patients with lymphoma were randomized 
equally to 1) care as usual (CAU), 2) PRO feedback, and 3) PRO feedback and Living with 
lymphoma. Patients completed questionnaires 9 to 18 months after diagnosis (T0; 
N=227) and 4 months later (T1; N=192). Outcomes were psychological distress (HADS), 
self-management (heiQ), satisfaction with information (ISQ), and healthcare use.  
 
Results  
No effects of PRO feedback with or without Living with lymphoma was observed on 
psychological distress, self-management, satisfaction with information provision, and 
healthcare use. PRO feedback was viewed by 77% of those with access. Of those with 
access to Living with lymphoma, only 36% accessed and registered and only 16 patients 
opened at least one part of the intervention.  
 
Conclusion  
No effects of PRO feedback on psychological distress, self-management skills, 
satisfaction with information provision, or healthcare use were found. As PRO feedback 
meets patients’ wishes to gain insight in their PROs and does not negatively impact their 
well-being, it might be implemented in daily clinical practice. Since the uptake and 
adherence of Living with lymphoma was very limited, no definite conclusions about the 
effectiveness of Living with lymphoma in a population-based sample can be drawn yet. 









About 25% of patients with lymphoma experiences persistent levels of anxiety, 
depressive symptoms and fears [1], also known as psychological distress. As 
psychological well-being is determined by the balance between stress and the 
resources available for coping [2,3], psychological distress may exaggerate when 
the right information and support is not available [4,5] and may lead to increased 
healthcare use [6]. Prior research showed that one third of patients with lymphoma 
are not satisfied with the information provision and would have liked more 
information, for example about supportive care [7].  
 
Based on the wishes of patients to get access to their own patient-reported 
outcome (PRO) data [8], an application has been developed to provide patients 
with feedback. PRO feedback enables patients to monitor their functioning, 
compare their scores with peers [8], and to be aware of and recognize symptoms. 
Subsequent steps, such as self-management interventions may be necessary to 
actually improve health outcomes [9]. Self-management interventions intend to 
enhance patients’ knowledge and skills and empower patients to play an active 
role in the management of their disease and its consequences [10,11], which is 
needed to keep up a good health-related quality of life (HRQoL). Increased self-
management may limit the burden on health services [12,13], which is desirable as 
the number of lymphoma survivors continues to grow.  
 
The Lymphoma InterVEntion [LIVE] trial consists of two interventions [14]: (1) PRO 
feedback to patients, including comparison with peers, and (2) a web-based self-
management intervention: Living with lymphoma. Living with lymphoma is based 
on psychoeducation and cognitive behavioural therapy (CBT), components shown 
to be effective in coping with cancer [15]. Although beneficial effects have been 
demonstrated among patients with breast cancer [16], little is known about the 
effects of such interventions in a population-based setting with unselected patients 
with cancer. 
 
The primary aim of the LIVE randomized controlled trial (RCT) is to examine the 
effects of PRO feedback to patients with or without access to Living with lymphoma 
on self-management, satisfaction with information, and psychological distress in a 
population-based setting [14]. We hypothesized PRO feedback with or without 







information provision, while reducing psychological distress. Based on new insights 
that psychologically distressed patients reported increased healthcare use [6], we 
added an additional aim to investigate the effects of PRO feedback with or without 
Living with lymphoma on healthcare use. 
METHODS  
 
Design and participants 
The RCT was embedded in the population based Patient Reported Outcomes 
Following Initial treatment and Long term Evaluation of Survivorship (PROFILES) 
registry [17], that enables PRO data collection management and linking these data 
to clinical data from the Netherlands Cancer Registry (NCR). 
 
Between October 2015 and February 2019, patients diagnosed with lymphoma (i.e., 
Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), or chronic lymphocytic 
leukemia (CLL)), as defined by the International Classification of Diseases for 
Oncology-3 codes (ICD-O-3) [18], from thirteen hospitals in the Netherlands were 
selected for participation 9 to 18 months after diagnosis. The NCR registers all 
newly diagnosed patients with cancer in the Netherlands within the first year after 
diagnosis and routinely collects detailed data on sociodemographic and clinical 
characteristics (e.g., patients’ age and sex, date of cancer diagnosis, cancer type, 
and primary treatment). Treating hemato-oncologists were asked to verify patients’ 
eligibility. Eligible patients were invited to participate in the RCT and complete a 
questionnaire. Patients were informed that completion of the web-based 
questionnaire resulted in RCT enrolment with automatic randomization to one of 
the three study groups, whereas paper respondents were only observationally 
followed within the PROFILES lymphoma registry. A reminder mail was sent after 
three weeks. All respondents received a follow-up questionnaire four months after 
the baseline questionnaire. The RCT was centrally and locally approved by a 
Medical Research Ethics Committee [14]. 
 
Randomization  
Randomization was performed using block randomization to ensure a balance in 
sample size across groups over time [19]. Participants were randomized equally to: 
1) care as usual (CAU), 2) CAU plus access to PRO feedback, or 3) CAU plus access 






Interventions versus CAU 
Group 1: CAU 
In arm 1, patients received CAU from their healthcare providers (e.g., hemato-
oncologists, oncology nurses). Most healthcare providers provided verbal 
information to their patients and gave them leaflets regarding the diagnosis and 
treatment they received.  
Group 2: PRO feedback  
In group 2 and 3, after patients completed the web-based questionnaire, PRO 
feedback was automatically generated. Patients could choose to either click on the 
‘feedback’ button to review the PRO feedback or not.  
 
Detailed information about the PRO feedback has been described elsewhere [8,14]. 
In short, PRO feedback was provided on patients’ general HRQoL, physical, 
emotional, cognitive and social functioning, fatigue, neuropathy, anxiety and 
depressive symptoms [14]. Individual scores were integrated into graphical displays 
with colored bar-charts [20,21]. Patients had the opportunity to compare their 
scores to mean scores of other patients with lymphoma [7] and/or an age- and 
sex-matched normative population without cancer [22] to discover whether their 
scores were average or not. The colors of the bar-charts were related to clinically 
relevantly mean differences of the evidence-based guidelines of the EORTC QLQ-
C30 [23] and considered ‘average’ (amber); ‘above average’ (green); or ‘below 
average’ (red). Patients with above average scores on symptoms were advised to 
contact their general practitioner.  
Group 3: PRO feedback + Living with lymphoma 
In addition to PRO feedback, patients in arm 3 had access to a web-based self-
management intervention: Living with lymphoma. A detailed description of Living 
with lymphoma has been previously described elsewhere [14]. Living with 
lymphoma, an adaptation of the BREATH intervention for breast cancer [16,24], 
was based on psychoeducation and CBT techniques to enhance patients’ 
knowledge and skills. The intervention also includes a library with background and 
additional information on various subjects (e.g., work, sexuality, lifestyle) and links 
to additional healthcare services (e.g., psychologists, physiotherapists). It was left 
to the discretion of the patients how and to what extent they used the intervention. 
The intervention was fully-automated, non-guided and was delivered without 









Sociodemographic and clinical information were obtained from the NCR. NCR data 
were available for both RCT participants and nonparticipants. Among RCT 
participants, information about education, partner and comorbid conditions was 
assessed in the questionnaire.  
 
Self-management skills were assessed with the Health Education Impact 
Questionnaire (heiQ) including 40 items across 8 scales [25]. Each item was scored 
on a 4-point scale. Scale scores were obtained by computing the mean of 
respective items. Higher scores indicate better status or self-management, except 
for emotional distress, where higher scores indicate higher distress [25].  
 
Satisfaction with information was assessed with an adapted version of the 9-item 
Information Satisfaction Questionnaire (ISQ) [26]. Patients were asked to categorize 
themselves into those who would like (1) all available information; (2) only positive 
information about the illness; and (3) only limited information. In addition, patients 
had to categorize themselves into those who would like (1) to be involved in 
decisions about the illness; (2) prefer the doctor to make the decisions. Patients 
were furthermore asked to rate their level of information satisfaction about their 
illness, treatment, and lifestyle. Questions were scored on a five-point scale.  
 
Psychological distress was assessed with the 14-item Hospital Anxiety and 
Depression Scale (HADS) [27]. Higher sum scores indicate higher levels of 
psychological distress [28]. Patients with a HADS sum score ≥13 were categorized 
as “distressed” [29]. 
 
Two open questions were asked to assess healthcare use: 1) “How often did you 
contact a general practitioner (GP) in the past 12 months?” and 2) “How often did 
you visit a medical specialist in the past 12 months?”.  
 
Statistical analyses 
All statistical analyses were performed with SAS version 9.4 (Cary, NC, USA). With 
more than 74 participants per study group, the study had 90% power to detect an 
effect size of .50 with a two-tailed P value set at .05 [30].  Baseline characteristics 
between the study groups were compared using analysis of variance and chi-





missing items were replaced by the average of those that are present for the 
participant.  
 
To model between-group difference in change from baseline to follow-up, mixed-
effect models were used with an unstructured covariance structure and a restricted 
maximum likelihood solution [31]. A random intercept on the patient-level was 
included in the model to adjust for the inter-dependency between repeated 
measures. The CAU-group (group 1) was assigned as the reference group. The P 
value for overall model effects was set at .05 and for specific contrasts at .01, 
lowering the risk of type I errors as a result of multiple testing. In the iterative 
process of variable selection, a priori selected covariates (i.e., age, sex, cancer type, 
treatment) were removed from the as they were non-significant and non a 
confounder. We adjusted for baseline psychological distress in all analyses (when 
this was not our outcome variable), since participants in the group 1 seemed 
somewhat more often psychologically distressed (22%) than those in group 2 (12%) 
and group 3 (11%, P=.10, data not shown).  
 
Group difference form baseline to follow-up in mean change were accompanied 
by Cohen’s ES. Cohen’s ES was calculated by dividing the difference in mean 
change scores between the control and intervention group by the pooled baseline 
standard deviation. An ES of .20 was considered small, .50 moderate, and .80 large. 
An ES of approximately .50 was considered to be clinically relevant [30,32]. All 
analyses were conducted on an intention-to-treat basis.  
RESULTS 
 
Baseline characteristics of RCT participants 
In total, 1,193 patients were selected from the NCR. After verifying eligibility, 892 
patients were invited to participate. Forty-nine percent declined to participate 
(n=436) and 229 patients completed the questionnaire on paper and were 
excluded. As depicted in the CONSORT diagram (Figure 1), both patient who 
declined participation and those who responded on paper were considered 











Note. CAU=care as usual; ITT=Intention To Treat analyses, comparing all respondents in both intervention 
groups to all respondents in the CAU group; NCR=Netherlands Cancer Registry; PRO=Patient-Reported 
Outcome.  
 
Figure 1. CONSORT Flow diagram of the progress of the patients with lymphoma through 
the phases of the LIVE trial 
  
Allocation 
Patients were selected from the NCR and 
assessed for eligibility by their hemato-
oncologists (n=1193) 
Patients were invited to participate 
(n=892) 
Excluded (n=296) 
• Not meeting inclusion 
criteria (n=291) 
• Other reasons (n=5) 
Excluded (n=665) 
• Declined to participate 
(n=436)  




CAU (n=77) PRO feedback (n=74) PRO feedback + Living with 
lymphoma (n=76) 
4 months follow-up 
CAU (n=64) 
Lost to follow-up (n=13) 
 
4 months follow-up 
PRO feedback (n=62) 
Lost to follow-up (n=12) 
 
4 months follow-up 
PRO feedback + Living with 
lymphoma (n=66) 





 ITT: (n=74) 
















Two-hundred and twenty-seven patients provided written informed consent, 
completed the first questionnaire online, and were randomly assigned to the PRO 
feedback with access to Living with lymphoma group (n=77), the PRO feedback 
group (n=74), or the CAU group (n=76). The completion rate of the follow-up 
questionnaire was 85% (n=192) and did not differ significantly among groups.  
 
RCT participants were younger than nonparticipants (60.7 vs 65.3 years, P<.01), 
and more often men (71% vs 57%; P<.01). RCT participants were on average 14.0 
months after diagnosis. The majority of RCT participants had a partner (84%). 
Seventy-one percent received active treatment, whereas 23% was on active 
surveillance and did not receive active treatment (Table 1). All baseline 
sociodemographic and clinical characteristics were balanced across groups.  
 
Intention-to-treat analyses 
Results of the intention-to-treat analyses indicated no significant group-by-time 
interaction for psychological distress, all self-management skills, satisfaction with 
information provision, and healthcare use (P>.05, Table 2). Differences on outcome 
variables did not seem to depend on the intervention patients received, which 
ensured that we should not look further at specific contrasts.  
 
Use of the Living with lymphoma intervention 
In total, 76 patients were randomized to group 3 and had access to Living with 
lymphoma, of whom 27 patients (36%) accessed and registered. No differences 
were observed in baseline sociodemographic and clinical characteristics between 
those who accessed and who did not. Of those who accessed Living with 
lymphoma, 16 patients (59%) opened at least one part of the intervention and were 
therefore assessed as users. In addition, various items from the library were viewed 
by the users: ‘Reliable information’ was opened 12 times, ‘Fatigue’, ‘Emotional 
counselling’, and ‘Nutrition and cancer’ were opened 6 times, ‘Exercise’ was 
opened 5 times and ‘Physical counselling’, ‘Sexuality’, and ‘Reintegration’ were 
opened twice. 
 
As we observed that adherence was very low, we asked patients about reasons for 
nonadherence and they indicated they felt well and still had regular appointments 















 n(%) n(%) P 
Sociodemographic characteristics    
Age in years: mean (SD) 60.7 (13.4) 65.3 (15.7) <.01 
Sex   <.01 
Male  161 (71) 377 (57)  
Female 66 (29) 289 (43)  
Marital status    
Partner  190 (84) N/A  
No partner 37 (16) N/A  
Educational level#    
Low 6 (3) N/A  
Medium 106 (47) N/A  
High 114 (50) N/A  
Clinical    
Months since diagnosis: mean (SD) 14.0 (3.2) 14.0 (3.5) .80 
Cancer type   .95 
HL 27 (12) 75 (11)  
NHL-HG 125 (55) 359 (54)  
NHL-LG 56 (25) 169 (25)  
CLL 19 (8) 63 (9)  
Treatment   .13 
Active treatment 172 (76) 458 (69)  
No active treatment  53 (23) 199 (30)  
Unknown 2 (1) 9 (1)  
No. of comorbid conditions 1.1 (1.1) N/A  
Note. The numbers may not always add up to 100, because percentages have been rounded off to 
whole numbers. 
Abbreviations: CLL, chronic lymphocytic leukemia; HL, Hodgkin lymphoma; NHL-HG, high-grade non-
Hodgkin lymphoma, NHL-LG, low-grade non-Hodgkin lymphoma; SD, standard deviation. 
# For education, low indicates none/primary school; medium, lower general secondary education/ 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Access to PRO feedback 
In total, 150 patients were randomized to group 2 or 3 and had access to PRO 
feedback, of whom 115 patients (77%) actually viewed the PRO feedback. Thirty-six 
patients (31%) viewed the feedback once, whereas the remainder viewed it more 
than once. Thirteen patients (13%) viewed the PRO feedback more than five times. 
Those who viewed the PRO feedback were more recently diagnosed (15.0 months 
vs 13.6 months, P=.03) and more often wanted to receive all available information 
about the disease than those who did not (59% vs 29%, P<.01). 
 
Ninety-two patients (80%) wanted to compare their scores to both other patients 
with lymphoma and a normative population without cancer, 13 patients (11%) only 
to other patients with lymphoma, and 1 patient only to a normative population. In 
addition, 9 patients (8%) only viewed their own scores.  
DISCUSSION 
 
The results of this RCT did not support our hypothesis that PRO feedback, with or 
without access to Living with lymphoma, has a beneficial effect on psychological 
distress, self-management skills, satisfaction with information provision, and 
healthcare use among patients in a population-based setting. Although no 
beneficial effects were observed, we have not found any negative effects of PRO 
feedback, with or without access to Living with lymphoma on patients’ well-being 
either. 
 
The majority (77%) of those with access, actually viewed the PRO feedback, of 
whom two-thirds viewed it more than once. Nevertheless, as up to a quarter was 
not interested in viewing PRO feedback, it is important that patients can decide for 
themselves whether or not they want to view the feedback. It is known that PRO 
feedback may particularly be effective in identifying problems, but intervening 
steps are necessary to actually improve outcomes [34].  
 
In contrast to the BREATH intervention that was found to be effective in reducing 
psychological distress and increasing self-efficacy among breast cancer survivors 
[16], we did not find an effect of Living with lymphoma on our outcome variables. 
To prevent patients from being dependent on healthcare providers to identify 
problems and refer them for intervention, we chose to make the intervention 







analyses demonstrated greater uptake of interventions aiming to reduce 
psychological distress among unselected patients compared to pre-screened 
patients [35,36], uptake and adherence rates in this sample were very low. Only 
36% of those with access, actually accessed the intervention and registered. Sixteen 
patients of those who registered, opened at least one part of Living with lymphoma 
and were assessed as users. There is evidence that unguided self-management 
interventions to reduce psychological distress could be more effective when 
targeted to those with the greatest need of an intervention, such as low-distress 
patients [16,37]. In our sample only 15% of participants were psychologically 
distressed, which is significantly lower than the 25% that was previously observed 
among a similar group of patients [1]. This might suggest that the need for 
intervention in our sample may be low and we may have not reached the right 
sample. However, our aim was explicitly to investigate effectiveness of the 
intervention in an unselected group of patients with lymphoma. In addition, timing 
of the intervention may not have been optimal, as participants were on average 14 
months post diagnosis and mostly finished primary treatment. Patients on 
treatment more frequently reported psychological distress compared with short- 
and long-term survivors [38]. Interventions closer to diagnosis or during active 
treatment may be more effective, as patients are especially vulnerable to 
psychological distress in that specific time frame.  
 
Some other limitations of this RCT should be noted. Participants were not 
representative of the lymphoma population, as they were younger, more often 
male, and more often highly educated [33]. More research is needed to 
understand why underrepresented patients were not reached and how they could 
be reached in the future. Furthermore, low uptake and adherence rates for Living 
with lymphoma limited its potential impact. Supporting intervention adherence by 
someone who guides patients through the intervention, with weekly email or 
telephone calls providing guidance, may be necessary to increase usage and 
completion of relevant modules of the web-based intervention.  
 
In conclusion, no effects of PRO feedback on psychological distress, self-
management, satisfaction with information, or healthcare use were found. As PRO 
feedback meets patients’ wishes to gain insight in their PROs and does not 
negatively impact their well-being, it might be implemented in daily clinical 
practice. No definite conclusions about the effectiveness of Living with lymphoma 





adherence of Living with lymphoma was very limited. More research is needed to 
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Randomized controlled trials (RCTs) often provide accurate estimates of the internal 
validity of an intervention but lack information on external validity (generalizability). We 
conducted an RCT on the effectiveness of a self-management intervention among 
patients with lymphoma in a population-based setting. The objectives of the current 
study were to describe the proportion of RCT participants compared to all patients 
invited to participate, and compare sociodemographic and clinical characteristics of RCT 
participants with all respondents, all patients invited to participate, and all patients 
selected from the Netherlands Cancer Registry (NCR) to determine the reach of the 
intervention. An additional objective was to assess differences on RCT outcome 
variables between RCT and paper respondents. 
 
Methods 
Patients with lymphoma or chronic lymphocytic leukemia ≥18 years old at diagnosis 
from 13 hospitals in the Netherlands were selected from the population-based NCR, 
which routinely collects data on sociodemographic and clinical characteristics. Eligible 
patients were invited to participate in an RCT and complete a questionnaire. Web-based 




A total of 1193 patients were selected from the NCR, 892 (75%) of whom were invited 
to participate in the trial by their hematologist after verifying eligibility. Among those 
invited, 25% completed the web-based questionnaire and were enrolled in the RCT. 
The RCT participants were younger and there was a higher proportion of men than 
non-participants. In addition, 26% of those invited opted to participate in the paper-
based observational follow-up study. Compared with paper respondents, RCT 
participants were younger, with a higher proportion of men, and had higher education 
levels. RCT participants more often wanted to receive all available information on their 
disease, whereas paper respondents reported higher levels of emotional distress.  
 
Conclusions 
From a population-based sample of eligible patients, the participation rate in the RCT 
was approximately 25%. RCT participants may not be representative of the target 
population because of different sociodemographic and clinical characteristics. Since 
RCT participants represent a minority of the target population, RCT results should be 








Randomized controlled trials (RCTs) are widely considered to be the gold standard 
for evaluating the effects of an intervention in behavioral and psycho-oncological 
research [1,2]. In contrast to the effects of interventions that are most often 
examined extensively in RCTs [3], much less attention has been paid to the 
proportion of patients who participate in these interventions and whether those 
who choose to participate are representative of the target population in terms of 
sociodemographic and clinical characteristics [2,4]. Thus, RCTs often provide 
accurate estimates of the internal validity (i.e., effect of an intervention for the 
sample enrolled in the RCT), but do not typically provide information about the 
external validity or generalizability (i.e., effect of an intervention in the target 
population) [5-7]. 
 
The reach of an RCT provides information on the absolute number, proportion and 
representativeness of the sample that participates in the trial [8]. The absolute 
number and proportion of RCT participants are relatively easy to assess and are 
therefore most often reported. However, few studies report the representativeness 
of the sample enrolled in an RCT, which is a much more challenging metric to 
assess [8,9], since it requires sociodemographic information, and preferable 
psychosocial, clinical or case mix information on RCT participants as well as non-
participants. It is particularly challenging to collect information on non-participants 
who typically do not consent to be included in the research [8].  
 
Interventions with promising effects in RCTs have been implemented in daily 
practice without specific knowledge of the generalizability of the results. Therefore, 
more attention should be paid to providing information related to the 
representativeness of the sample enrolled in an RCT. Lack of representativeness 
may occur as a result of inadequate selection procedures (i.e., sampling bias) or 
when the probability of non-participation in the study is related to the object of 
research (i.e., non-response bias) [10,11].  
 
To fill this gap, the aim of the current study was to address the reach of a web-
based self-management intervention within the context of the Lymphoma 
InterVEntion [LIVE] trial, whose objectives have been described elsewhere [12]. For 
the LIVE-trial, patients were selected from the population-based Netherlands 







clinical characteristics. This can provide unique insight into the characteristic 
differences between RCT participants and non-participants to estimate the reach 
of this intervention. The primary objectives were to (1) describe the proportion of 
RCT participants compared to all patients invited to participate, and (2) compare 
sociodemographic and clinical characteristics of RCT participants with those of all 
respondents (i.e., patients who completed a web-based or paper questionnaire), 
all patients invited to participate, and all patients selected from the NCR. In 
addition, as patients had the option of completing a web-based questionnaire (i.e., 
enrollment in the RCT) or a paper-based questionnaire (i.e., no enrollment in the 
RCT, observational cohort), a secondary objective was to assess baseline 
differences in psychological distress, self-management skills, and satisfaction with 




Baseline data were collected from an RCT embedded in a population-based 
registry [13] as an observational cross-sectional dataset without information on the 
effectiveness of the intervention. In short, the LIVE-trial examines the effectiveness 
of feedback on patient-reported outcomes and a web-based self-management 
intervention on self-management skills, satisfaction with information provision, and 
psychological distress among patients with lymphoma [12]. 
 
Participants and recruitment procedure 
From October 2016 to February 2019, patients who were diagnosed with 
lymphoma (i.e., Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), or 
chronic lymphocytic leukemia (CLL)), as defined by the International Classification 
of Diseases for Oncology-3 codes (ICD-O-3) [14], from 13 hospitals in the 
Netherlands were selected for participation via the NCR. The NCR registers all 
patients newly diagnosed with cancer in the Netherlands within the first year after 
diagnosis and routinely collects detailed data on sociodemographic and clinical 
characteristics (e.g., patient age and sex, date of cancer diagnosis, cancer type, and 
primary treatment). Patients had to be 18 years or older at time of study invitation. 
Treating hematologists were asked to verify the patients’ eligibility for the study 
and to exclude patients who were deceased, had severe psychopathology, were 
too ill, were not able to complete a questionnaire in Dutch, or had severe cognitive 





hematologist. Patients had the option to complete a web-based or paper-based 
questionnaire. Patients were informed that completion of the web-based 
questionnaire automatically resulted in enrollment in the RCT with randomization 
to one of the study arms, whereas completion of a paper questionnaire resulted in 
participation in the observational Patient Reported Outcomes Following Initial 
treatment and Long term Evaluation of Survivorship (PROFILES) lymphoma registry 
[13] but not enrollment in the RCT. To address the primary objective of the current 
study – describing the proportion of RCT participants compared to all patients 
invited to participate – paper respondents were assessed as nonparticipants as 
they did not participate in the RCT.  
 
Measures 
Sociodemographic and clinical measures 
Sociodemographic characteristics (age and sex) and detailed clinical information 
(date of diagnosis, cancer type, primary treatment) were available from the NCR. 
Information on education level and marital status was assessed from the 
questionnaire (data only available for respondents). Comorbidities at the time of 
questionnaire completion were assessed using an adapted version of the Self-
Administered Comorbidity Questionnaire [15]. Patients were asked to identify 
comorbidities present within the past 12 months, including heart disease, 
hypertension, arthritis, stroke, lung disease, diabetes, stomach disease, kidney 
disease, liver disease, anemia, thyroid disease, and rheumatoid arthritis. Positive 
responses were summed to a total score ranging from 0 to 12 (data only available 
for respondents).  
Personality traits 
Personality traits were assessed with the Big Five Inventory, a 44-item inventory 
designed to measure the Big Five dimensions of personality: extraversion, 
neuroticism, conscientiousness, agreeableness, and openness to experience [16]. 
Each item was scored on a 5-point scale. Scale scores were obtained by averaging 
all items for each domain ranging from 0 to 5. Each trait is assumed to represent 
a continuum from high to low on the specific attribute and is partnered with a trait 
on the opposite pole of the spectrum [17,18].  
Information preferences 
One question from an adapted version of the Information Satisfaction 
Questionnaire was used to measure information preferences [19]. Patients had to 







available information, (2) only positive information about the illness, and (3) only 
limited information. Patients were further asked whether they use the internet 
(yes/no).  
Psychological distress, self-management skills, and satisfaction with information 
provision 
Primary outcomes to assess the effectiveness of the intervention were 
psychological distress, self-management skills, and satisfaction with information 
provision. 
 
Psychological distress was assessed with the 14-item Hospital Anxiety and 
Depression Scale (HADS) [20]. Each item is rated on a 4-point scale from 0 to 3. 
The total score was obtained by adding all item scores and ranged from 0 to 42, 
in which higher scores indicate higher levels of psychological distress [21]. Patients 
with a HADS total score ≥13 were categorized as “psychologically distressed” [22]. 
 
Self-management skills were assessed with the Health Education Impact 
Questionnaire (heiQ) that contains 40 items across 8 scales: positive and active 
engagement in life, health-directed activities, skill and technique acquisition, 
constructive attitudes and approaches, self-monitoring and insight, health service 
navigation, social integration and support, and emotional distress [23]. Each item 
is scored on a 4-point scale. Scale scores were obtained by averaging all items for 
each domain and ranged from 1 to 4. Higher scores indicate better status or self-
management, except for emotional distress in which higher scores indicate greater 
distress [23].  
 
Satisfaction with overall information provision was assessed with one item from an 
adapted version of the Information Satisfaction Questionnaire [19]. Patients were 
asked to rate their level of satisfaction for overall information provision on a scale 
from 1 (“very unsatisfied”) to 5 (“very satisfied”). 
 
Statistical analyses  
The proportion of RCT participants (i.e. participation rate) was calculated by 
dividing the number of patients who were enrolled in the RCT by the total number 
of eligible patients who were invited to participate. Sociodemographic and clinical 
characteristics of RCT participants were compared with those of all respondents 
(i.e., patients who completed a web-based or paper-based questionnaire), all 





NCR. In addition, personality traits and information preferences of RCT participants 
were compared with those of all respondents. Differences on sociodemographic 
and clinical characteristics between RCT participants and non-participants were 
compared using analysis of variance for continuous variables and chi-square tests 
for categorical variables. Differences in baseline psychological distress, self-
management skills, and satisfaction with information provision (i.e., RCT outcome 
variables) between RCT participants and paper respondents were compared using 
analysis of variance for continuous variables and chi-square tests for categorical 
variables. All statistical analyses were performed with SAS version 9.4 (Cary, NC, 
USA). P≤.05 indicated statistically significant differences.  
RESULTS 
 
Patients selected from the NCR 
As shown in Figure 1, a total of 1193 patients with lymphoma or CLL who were ≥ 18 
years old at diagnosis from 13 hospitals were selected from the population-based 
NCR. The basic characteristics if the invited patients are summarized in Table 1. The 
majority of patients were men, were diagnosed with high-grade NHL, and were 
actively being treated, with chemotherapy as the most common treatment. 
 
Patients invited to participate  
A flowchart of the patient selection process is shown in Figure 1. Of all selected 
patients, 25% (296/1193) were excluded after verifying eligibility by their treating 
hematologists for the following reasons: deceased, severe psychopathology, too 
ill, insufficient proficiency of the Dutch language, and cognitive impairment. In 
addition, 156 patients were not eligible for other reasons, including 36 patients who 
received treatment or follow-up in another hospital and 20 patients for whom the 
ultimate diagnosis did not meet our inclusion criteria (e.g., myelodysplastic 
syndrome, acute lymphoblastic leukemia). The remaining 100 patients were 
excluded by the hematologists for unknown reasons. Furthermore, five patients 
were excluded as they declined participation in previous studies within the 
PROFILES registry. After exclusion of these patients, 892 patients (75%) were invited 
to participate and completed a questionnaire. Patients invited to participate did 
not significantly differ from all patients selected from the NCR in terms of age 
















Respondents RCT participants 
 (N=1193) (N=892) (N=456) (N=227) 
 n(%) n(%) n(%) n(%) 
Sociodemographic 
characteristics     
Age in years: mean (SD) 64.7 (15.6) 64.1 (15.3) 64.5 (13.5) 60.7 (13.4) 
Sex     
Male 725 (61) 537 (60) 291 (64) 161 (71) †, ‡ 
Female 468 (39) 355 (40) 165 (36) 66 (29) 
Education level #     
Low N/A N/A 33 (7) 6 (3) 
Medium N/A N/A 260 (58) 106 (47) 
High N/A N/A 159 (35) 114 (50) 
Partner (yes) N/A N/A 355 (79) 190 (84) 
Clinical characteristics     
Months since diagnosis: mean 
(SD) 13.9 (3.5) 14.0 (3.4) 14.2 (3.3) 14.0 (3.2) 
Cancer type     
HL 120 (10) 102 (11) 46 (10) 27 (12) 
NHL-HG 676 (57) 484 (54) 260 (57) 125 (55) 
NHL-LG 280 (23) 224 (25) 114 (25) 56 (25) 
CLL 116 (10) 82 (9) 36 (8) 19 (8) 
Primary treatment     
Active surveillance 315 (26) 252 (28) 113 (25) 53 (23) 
CT alone 522 (44) 405 (45) 222 (48) 109 (48) 
RT alone 80 (7) 70 (8) 31 (7) 11 (5) 
CT + RT 103 (9) 90 (10) 51 (11) 29 (13) 
SCT ± CT ± RT 30 (3) 25 (3) 20 (4) 16 (7) 
Other  56 (5) 39 (4) 16 (4) 7 (3) 
Unknown 87 (7) 11 (1) 3 (1) 2 (1) 
Number of comorbidities: mean 
(SD) N/A N/A 1.3 (1.2) 1.1 (1.1) 
Personality traits     
Openness N/A N/A 3.4 (0.6) 3.5 (0.6) 
Conscientiousness N/A N/A 3.7 (0.5) 3.7 (0.4) 
Extraversion N/A N/A 3.5 (0.6) 3.5 (0.6) 
Agreeableness N/A N/A 3.8 (0.5) 3.8 (0.4) 
Neuroticism N/A N/A 2.5 (0.7) 2.4 (0.6) 















 (N=1193) (N=892) (N=456) (N=227) 
 n(%) n(%) n(%) n(%) 
Information preferences     
All available information N/A N/A 211 (47) 126 (56) 
Only positive information N/A N/A 65 (15) 23 (10) 
Limited information N/A N/A 170 (38) 78 (34) 
Internet use (yes) N/A N/A 370 (82) 220 (97) 
Abbreviations: CLL, chronic lymphocytic leukemia; CT, chemotherapy; HL, Hodgkin lymphoma; NHL-HG, 
high-grade non-Hodgkin lymphoma; NHL-LG, low-grade non-Hodgkin lymphoma; RCT, randomized 
controlled trial; RT, radiotherapy; SCT, stem-cell transplantation; SD, standard deviation.  
The groups in columns are not mutually exclusive; RCT participants are also included in the groups of the 
other 3 columns.  
# For education, low indicates none/primary school; medium, lower general secondary education/ 
vocational training; and high, pre-university education/high-level vocational training/university. 
† Statistically significantly different from all patients selected from the NCR (p<0.05). 
‡ Statistically significantly different from all patients invited to participate (p<0.05).  
 
Respondents  
Among the 892 invited patients, 456 patients (51%) responded and completed 
either a web-based or paper questionnaire. The mean age of all respondents 
(Table 1) was comparable with that of non-respondents (63.8 years, P=.43), and 
the majority of the respondents were also men. Respondents did not differ from 
all patients selected from the NCR in terms of age (P=.81) and sex (P=.26). 
Respondents were more often actively treated than non-respondents (75% vs 66%, 
P=.01). Half of the respondents completed a paper questionnaire (N=229), whereas 
the other half completed a web-based questionnaire and were enrolled in the RCT 
(N=227). Nearly half of the respondents (47%) stated that they would like to receive 
all available information, with a lower proportion preferring limited information 
(38%), and even less indicating that they would like to receive only positive 
information about the illness (15%) (Table 1). Approximately 82% of all respondents 
reported using the internet. 
 
RCT participants 
A quarter of all invited patients (227/892) participated by completing a web-based 







age of RCT participants was slightly lower than that of non-participants (i.e., non-
respondents and paper respondents; N=665, 65.3 years, P<.001) with a slightly 
higher mean time since diagnosis, and comprised a higher proportion of men (71% 
vs 57%, P<.001). The proportion of patients who were actively treated were 
comparable between RCT participants and non-participants (76% vs 69%, P=.13). 
In addition, RCT participants were significantly younger than respondents, patients 
invited to participate, and patients selected from the NCR (all P<.001). Furthermore, 
there was a higher proportion of men among RCT participants compared with all 
patients invited to participate and all patients selected from the NCR (both P<.001).  
 
RCT participants vs paper participants  
RCT participants were younger than paper respondents (60.7 vs 68.3 years, 
P<.001). In addition, RCT participants were more often male (71% vs 57%, P=.002), 
more highly educated (50% vs 20%, P<.001) and more often had a partner (84% 
vs 75%, P=.02). No significant differences were found between RCT and paper 
respondents regarding cancer type or primary treatment (P=.54 and P=.06, 
respectively). RCT participants also reported fewer comorbidities than paper 
respondents (1.1 vs 1.4, P=.02). 
 
Concerning personality traits, RCT participants had lower scores on neuroticism 
(2.4 vs 2.6, P=.003) and higher scores on openness to experience (3.5 vs 3.4, 
P=.002) than paper respondents, although effect sizes were small (Cohen d=.29 
and .28, respectively). With respect to information preferences, the majority of RCT 
participants stated a preference for receiving all available information, whereas 
only 39% of paper respondents indicated this preference (P=.001). Conversely, 
paper respondents more often preferred receiving limited information (42% vs 
34%, P=.001). Furthermore, RCT participants more often used the internet (97% vs 
66%, P<.001).  
 
Emotional distress, as measured with the heiQ, was significantly lower among RCT 
participants compared with the score of paper respondents (Table 2), although the 
effect size was small (Cohen d=.25).  
 
No significant differences were observed regarding other self-management skills 
between the RCT and paper groups. In addition, no significant differences were 
observed in the proportion of patients with psychological distress between RCT 





higher mean scores. Furthermore, no differences were observed between RCT 
participants and paper respondents regarding satisfaction with overall information 
provision (Table 2). 
 
Table 2. Differences in RCT outcome variables at baseline between RCT participants (N=227) 




respondents P Cohen’s d 
 (N=227) (N=229)   
 n(%) n(%)   
Psychological distress (yes) 34 (15) 45 (20) .18  
Psychological distress: mean (SD)# 6.5 (5.9) 7.5 (6.1) .06 .18 
     
Self-management skills: mean (SD)†     
Health-directed behavior 3.3 (0.6) 3.2 (0.6) .12 .14 
Positive and active engagement in life 3.2 (0.5) 3.1 (0.5) .05 .18 
Self-monitoring and insight 3.0 (0.4) 3.1 (0.4) .62 .05 
Constructive attitudes and approaches  3.3 (0.5) 3.3 (0.5) .66 .04 
Skill and technique acquisition 2.9 (0.5) 3.0 (0.5) .33 .09 
Social integration and support 3.2 (0.5) 3.2 (0.5) .77 .03 
Health services navigation 3.3 (0.4) 3.3 (0.4) .54 .06 
Emotional distress 1.8 (0.5) 1.9 (0.6) .01 .25 
     
Satisfaction with overall information provision  .29  
Very unsatisfied  1 (0) 2 (1)   
Unsatisfied  9 (4) 8 (4)   
Neither  49 (22) 41 (18)   
Satisfied  126 (56) 143 (63)   
Very satisfied  41 (18) 27 (12)   
Abbreviations: RCT, randomized controlled trial; SD, standard deviation.  
# scale 0-42; higher score indicates more psychological distress 
† scale 1-4; higher scores indicate better status or self-management, except for emotional distress, in which 
higher scores indicate higher distress 
DISCUSSION 
Principal findings 
This reach analysis among RCT participants within a population-based sample 
showed a selective reach with an underrepresentation of older patients, women, 
and those with a medium to low level of education. In addition, our RCT 
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participants may represent individuals with relatively better psychological well-
being as scores for emotional distress were lower in this group. 
 
Approximately a quarter of the population-based sample of patients with 
lymphoma and CLL were assessed to be not eligible for the study for various 
reasons (e.g., deceased, severe psychopathology or cognitive impairment, a 
different diagnosis was ultimately made). Among the eligible patients who were 
invited to participate, 51% responded and completed a questionnaire, half of whom 
completed the web-based questionnaire and were enrolled in the RCT, resulting 
in a participation rate of 25%. This means that only one in four of all eligible patients 
actually participated in the RCT. This participation rate was lower compared with 
that of an RCT on the fully automated electronic health (eHealth) application 
Oncokompas that supports cancer survivors in their self-management (48%) [24]. 
Patients in the Oncokompas RCT were selected from the population-based NCR. 
However, cancer survivors in the Oncokompas RCT were first invited in an online 
survey study on supportive care and eHealth to assess internet use. Their 
participation rate was calculated as the number of RCT participants divided by the 
number of eligible respondents of the survey (access to the internet and email 
address). Thus, their group of eligible respondents was more selective compared 
with our sample. In our sample, only 82% of all respondents used the internet, and 
this percentage may be even lower among all patients invited to participate.  
 
The results of the current study demonstrate that the RCT participants were 
younger, more often men, and more often actively treated compared to non-
participants. Thus, the sample of RCT participants may not be representative of the 
target population. Therefore, even though the sample size reached the required 
number of patients [12], this sample may not be reliable for drawing conclusions 
about the target population. Furthermore, the effects of the intervention on the 
target population may be different from the effects that were found in the RCT 
sample [10,25]. 
 
These results also provide information about the response rate of observational 
research, which was 51%. This is comparable with response rates from other 
population-based studies on quality of life among lymphoma survivors in Germany 
(54.7%) [26] and the United States (54.8%) [27]. However, the current response 
rate is lower compared with that reported from earlier observational research 





recruitment procedures [28]. This might be explained by the knowledge that the 
more information that is disclosed about the study – which is inherently more for 
an RCT than for observational research – the higher the proportion of non-
respondents [29]. Patients received abundant information along with the invitation, 
especially about participation in an RCT and randomization. The amount of 
information, as well as the knowledge of being randomized when completing a 
web-based questionnaire may have deterred patients from participating. In 
addition, the type of intervention may have influenced the participation rate, as the 
majority of patients did not have problems with adjustment to cancer and therefore 
may have been less interested in a self-management intervention. Another 
explanation may be related to the fact that participation and response rates for 
health-related research have been declining over the past several years [30,31], 
and potential participants are faced with an increasing number of requests to 
participate in studies. This may result in patients refusing to participate in all studies 
[32].  
 
We further compared characteristics of RCT participants with those of paper 
respondents. RCT participants, who completed the web-based questionnaire, were 
younger, more often men, and more highly educated than the paper respondents, 
which is similar to the characteristics from previous observational studies within our 
study group [33,34]. Highly educated patients more often display prosocial 
behavior than patients with lower levels of education, and therefore the former 
group may be more likely to participate in an RCT for altruistic reasons [35]. In 
addition to differences in sociodemographic characteristics, RCT participants 
reported lower scores related to neuroticism and higher scores related to openness 
than paper respondents. In addition, information preferences slightly differed 
between RCT and paper respondents, as RCT participants more often wanted to 
receive all available information on their disease. RCT participants also more often 
reported using the internet. To complete a web-based questionnaire, and 
subsequently be enrolled in a web-based self-management intervention RCT, 
patients must not only be able to use a computer but also be sufficiently skilled in 
browsing the internet [33]. Although there seems to be a trend of older individuals 
becoming more active online [33,36], there is still a subgroup of patients who do 
not use the internet and thus have no access to a web-based questionnaire or 








Despite these various differences between RCT participants and paper participants, 
baseline scores on self-management skills, satisfaction with information provision 
and psychological distress appeared to be comparable between these groups, 
although scores for emotional distress were slightly lower among RCT participants.  
 
Strengths 
The strengths of this study include its unique setting. As patients were recruited 
from the population-based NCR, we had information on sociodemographic and 
clinical characteristics of both RCT participants and non-participants. In addition, 
as the RCT was embedded in the PROFILES registry, we were able to assess 
differences between RCT participants and paper respondents on 
sociodemographic and clinical characteristics, in addition to personality traits, 
information preferences, and baseline psychological distress, self-management 
skills, and satisfaction with information provision (i.e., RCT outcome variables). This 
information provided the opportunity to determine both the reach and 
generalizability of the RCT sample.  
 
Limitations 
The current study has some limitations. Although information regarding 
sociodemographic and clinical characteristics of non-participants was available, we 
did not have information about non-participants’ reasons for declining 
participation or their physical and psychological health. Therefore, it remains 
unclear whether the physical and psychological health of RCT participants is similar 
to that of non-participants. In a previous study that assessed the generalizability of 
the results of observational research among cancer survivors by comparing 
characteristics of participants and non-participants, sensitivity analysis 
demonstrated that quality of life might be lower among non-participants [34]. As 
RCT participants may have a systematically higher quality of life, or report fewer 
symptoms, compared to non-participants, observed outcomes may represent a 
group of healthier patients with better outcomes. This may lead to circumspection 
in generalizing the results of an RCT to the target population. It is important to 
keep this in mind when interpreting RCT results that may only represent a minority 
of the target population. 
  
Conclusions 
The participation rate in the RCT was 25%. RCT participants may be not 





clinical characteristics. RCT results should be considered with caution, as RCT 
participants represent a minority of the target population, and may actually be 
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In this chapter, the main findings of the studies described in this thesis are discussed 
in a broader context. In addition, methodological considerations and implications 
for clinical practice and future research are discussed. 
 
The first objective of this thesis was to make an inventory of factors that are 
associated with psychological distress (Part I). We started with investigating factors 
associated with an increased risk of psychological distress among patients with 
lymphoma (Chapter 2). We observed that neuroticism was the greatest factor 
associated with psychological distress. The association between neuroticism and 
psychological distress, however, was partially explained by passive coping 
strategies including anxious preoccupation and helplessness/hopelessness. In 
addition, younger age and comorbid conditions were associated with 
psychological distress. Next, we investigated the impact of lymphoma and 
psychological distress on the use of healthcare services (Chapter 3). Lymphoma 
survivors reported more medical contacts (i.e., contacts with the general 
practitioner (GP) or medical specialist) compared to a normative population 
without cancer. In addition, psychologically distressed survivors had even more 
medical contacts than those without psychological distress and received 
psychosocial care more often.  
 
The second part of this thesis focused on the development, evaluation, and reach 
of an intervention for patients with lymphoma to reduce psychological distress and 
increase satisfaction with information provision and self-management skills: the 
Lymphoma InterVEntion [LIVE] (Part II). We started this part with investigating 
whether patients with lymphoma wished to receive feedback on their patient-
reported outcomes (PROs), how they would like to receive this feedback, and how 
this feedback was evaluated (Chapter 4). The majority of patients (80%) wished to 
receive feedback on their PROs, of whom almost all patients wished to compare 
their scores with other patients with lymphoma. In addition, patients rated the PRO 
feedback as useful.  
 
Next, the rationale and study design of the LIVE randomized controlled trial (RCT) 
were presented (Chapter 5). The RCT consisted of two interventions: 1) feedback 
to patients on their PROs, and 2) a web-based self-management intervention 





distress, and increase self-management skills and satisfaction with information 
provision. Hereafter, the main effects of the PRO feedback and Living with 
lymphoma were described (Chapter 6). Neither positive, nor negative effects of 
PRO feedback with or without the use of the Living with lymphoma intervention 
were observed on psychological distress, self-management skills, satisfaction with 
information provision, and healthcare use. Last, the reach of our web-based self-
management intervention within the context of the LIVE trial was evaluated 
(Chapter 7). From a population-based sample of eligible patients, 51% completed 
the first questionnaire, of whom half completed a paper questionnaire and half 
completed a web-based questionnaire. Web-based completers were automatically 
randomized into one of the RCT arms, which resulted in an RCT participation rate 
of 25%. RCT participants were younger, more often male, and more highly 
educated compared to nonparticipants. Therefore, we cannot extrapolate the 
results of our RCT to all patients with lymphoma in the Netherlands. 
 
Together, the studies in this thesis described the process from making an inventory 
of factors associated with psychological distress among lymphoma survivors 
(Chapter 2 and 3) to the development (Chapter 4 and 5), evaluation (Chapter 
6) and reach (Chapter 7) of an intervention to reduce psychological distress and 
increase self-management skills and satisfaction with information provision: 
Lymphoma InterVEntion [LIVE]. This final chapter discusses the practical 
implications of the findings in more detail and some methodological 
considerations about the central approaches. At the end of this chapter, 




Factors associated with psychological distress 
Sociodemographic and clinical factors 
The results in this thesis indicate that sociodemographic, clinical, and psychological 
factors are associated with psychological distress among patients with lymphoma. 
We observed that younger age and the presence of comorbid conditions were 
associated with psychological distress. Our findings that younger age was 
associated with increased psychological distress was supported by an integrative 
review among hematological cancer survivors [1]. Various reasons can account for 







younger patients are more likely to receive aggressive lymphoma treatment [2], 
which is associated with greater side-effects and long-term late effects. In addition, 
younger patients may have more problems with adjustment to cancer because the 
disease and intensive treatment regimen can interfere substantially with their social 
and vocational needs [3], such as child care, missed work because of their cancer 
treatment or side effects, and lack of financial or employment stability. 
Furthermore, patients with more comorbid conditions had an increased risk of 
psychological distress. Previous studies showed that although the specific impact 
of cancer on psychological distress is smaller among patients with comorbid 
conditions than those without, each comorbid condition increases total 
psychological distress [3]. Thus, comorbid conditions interact with cancer to result 
in more symptoms and psychological burden.  
 
Moreover, other sociodemographic and clinical factors including sex, education, 
cancer type, and active treatment showed no significant association with distress 
in patients with lymphoma. 
Psychological factors 
Personality reflects patients’ characteristic patterns of thoughts, feelings, and 
behaviors [4] and it affects the way in which stressful situations are interpreted. It 
is recognized that substantial associations exist between personality and 
psychological distress [5]. The results of this thesis indicated that the personality 
trait of neuroticism – referring to stable tendencies to experience negative affects 
and to respond with negative emotions to threat, frustration, or loss [4] – was 
positively associated with psychological distress. A meta-analysis among adults in 
general demonstrated that neuroticism showed the strongest link to 
psychopathology [6], but several other traits showed substantial effects 
independent of neuroticism. Although personality traits are relatively stable and 
hard to change [7], they can be useful for identifying patients at risk for 
psychological distress [6]. 
 
In addition to the abovementioned factors, coping strategies have been 
considered important determinants of psychological distress in patients with cancer 
[8]. The results of this thesis revealed that passive coping strategies (i.e., 
‘Helplessness/Hopelessness’, ‘Anxious Preoccupation’) were positively associated 
with psychological distress and showed substantial effects independent of 





with previous literature that demonstrated a positive association between passive 
copings strategies and psychological distress among patients with different cancer 
types [9-11]. Passive coping refers to a sense of helplessness in dealing with the 
stressor and relying on others to resolve the stressful event or situation [12,13]. A 
sense of lack of control and inability to have impact on the stressful situation 
reinforces negative adjustment to cancer and psychological distress. The reliance 
on external resources is opposite to active coping (e.g., ‘Fighting Spirit’), in which 
patients rely upon their own resources to cope with the stressor. In literature, some 
inconsistencies exist about the association between active coping and 
psychological distress. Although some studies – including the findings in this thesis 
– did not reveal an association between active coping and psychological distress 
[9,10], others indicated that active coping was a protective factor for psychological 
distress [14-16].  
 
Impact of psychological distress on healthcare use 
In this thesis, it was observed that lymphoma survivors contacted their GP and 
medical specialist more often than an age- and sex-matched normative population 
without cancer. These results were in line with previous studies [17-21]. The number 
of GP contacts normalized over time, whereas the increased contacts with medical 
specialists persisted up to ten years after diagnosis. This may be due to the 
frequency of follow-up appointments as advised in the Dutch guidelines for 
treatment and follow-up of patients with lymphoma (www.hovon.nl). Furthermore, 
when looking at the impact of psychological distress on healthcare use, our results 
demonstrated that those who experienced psychological distress had even more 
contacts with their GP and medical specialist. It has been demonstrated that 
patients with psychological problems contact their GP almost twice as often – for 
both psychological and somatic problems – compared to those without 
psychological problems [22]. It is known that psychologically distressed patients 
are more likely to somatize, intensify their symptoms, and be more aware of bodily 
sensations, making them more likely to seek help from medical care services [23-
26]. These results suggest that the presence of psychological distress may impact 
the way and frequency lymphoma survivors access healthcare.  
 
The results in this thesis furthermore indicated that psychologically distressed 
patients not only had an increased use of medical services, but also received 
psychosocial care more often. Nevertheless, more than half of those scoring above 







survivors did not receive coping resources and psychosocial care services that may 
help to reduce psychological distress [27]. This is in line with previous literature 
[25,28-30]. It has been demonstrated that only one-third of patients scoring above 
the cutoff for psychological distress indicated a need for professional help with 
psychological distress [31]. There may be various reasons why psychologically 
distressed patients do not seek or engage in psychosocial care services. They may 
choose to rely on friends and family or prefer not to talk about their problems [32]. 
Moreover, it is known that lack of organizational and therapeutic integration of 
psycho-oncological services in routine oncology care may be a barrier to the use 
of psychosocial care services [33]. It has been demonstrated that those 
experiencing psychological distress and not receiving psychosocial care reported 
an increased use of medical care services [29]. Therefore, adequate recognition of 
psychological distress and appropriate care for those experiencing psychological 
distress may help to reduce the use of medical care services [25]. It is known that 
minimal psychosocial interventions may increase survivors’ quality of life and 
reduce overall healthcare expenditures [34].  
 
Interventions to reduce psychological distress 
Psychological distress and other adverse problems may increase when the right 
information and support is not available [35,36]. This may subsequently lead to 
increased use of healthcare services [37]. Interventions that provide patients with 
psychosocial support and adequate information have the potential to reduce 
psychological distress.  
 
Previous research showed that one third of lymphoma survivors were not 
(completely) satisfied with the information they received and would like to have 
more information, for example, about supportive care [38]. The results of this thesis 
indicate that approximately 75% of patients with lymphoma were satisfied with the 
information they received, which means that the proportion of patients who were 
not (completely) satisfied diminished to a quarter. Since information provision is 
often seen as a crucial tool for the support of cancer survivors – by facilitating their 
involvement in management of their health(care) [39] – it has been suggested that 
efforts are needed to improve the information provision for lymphoma survivors. 
Furthermore, as mentioned before, it is known that many survivors do not receive 
coping resources and psychosocial support services that may help them to reduce 
their psychological distress [27]. It has been suggested that an intervention that 





psychological distress. In this thesis, two interventions were developed that aimed 
to increase patients’ self-management skills and satisfaction with information 
provision, and reduce psychological distress. 
 
Impact of PRO feedback to patients and a web-based self-management 
intervention on patient reported outcomes 
Based on the wishes of patients to get insight in their own PRO data, an application 
within the PROFILES registry has been developed to provide feedback on PROs 
directly to patients instead of via healthcare providers. PRO feedback directly to 
patients enables patients to self-monitor their physical and psychosocial 
functioning, which could increase awareness and early recognition (in changes) of 
symptoms. The findings in this thesis indicate that 80% of those in the pilot study 
and 77% of those with access to PRO feedback in the RCT consulted the PRO 
feedback. Survivors who consulted the PRO feedback had similar scores on 
psychological distress compared to those who did not. In addition, the results of 
this thesis indicate that lymphoma survivors considered the PRO feedback as 
useful, especially the option to compare their scores with other lymphoma 
survivors with the same age and sex. This may help them to either reassure that 
what they experience is ‘normal’ or may motivate them to take action and discuss 
their problems with a healthcare professional. These findings suggest that inclusion 
of PRO feedback directly to patients may increase patient involvement and help 
patients to feel more in control of their care.  
 
No evidence of a beneficial effect of PRO feedback to patients on psychological 
distress, self-management skills, and satisfaction with information provision was 
found in this thesis. Moreover, the PRO feedback neither had adverse effects on 
these outcomes and thus not induces fears or anxiety compared to the control 
group. Early recognition and discussion of adverse problems with healthcare 
providers is important. Appropriate referral to psychosocial care in cancer survivors 
may subsequently contribute to decreased use of medical healthcare services.  
 
Self-monitoring of symptoms may be a good first step for early symptom 
recognition. Providing PRO feedback to patients however may not be sufficient to 
ensure a reduction in psychological distress. Previous literature showed that 
providing feedback on PROs is particularly effective in the identification and 
creation of awareness of problems and unmet needs, but intervening steps may 








Nevertheless, face-to-face psychosocial interventions are costly and often 
associated with prolonged waiting periods for individuals in need for psychosocial 
care. These waiting periods are disadvantageous for both individuals seeking help 
as the healthcare system, as it has been demonstrated that those in need for help 
use more unspecific healthcare services [29]. Therefore, appropriate interventions 
should be offered to those unable to receive immediate professional psychosocial 
care. Web-based interventions can be applied flexibly, with comparably little time, 
and personnel resources [41,42]. The implementation of web-based self-help 
interventions may be a possibility to produce relief for those waiting for 
psychosocial care or those with symptoms that may be too mild to be considered 
for professional support.  
 
Living with lymphoma is a web-based self-management intervention that aims to 
increase self-management skills and satisfaction with information provision, and 
reduce psychological distress. It is an adaptation from the evidence-based BREAst 
cancer e-healTH (BREATH) intervention [43,44] and is based on psychoeducation 
and cognitive behavioral therapy (CBT). Previous research demonstrated that 
interventions based on CBT – that combine emotion, cognition, and behavior – 
may help patients to better cope with the stress of the cancer experience [45]. 
Although the efficacy of the web-based BREATH intervention for the reduction of 
mild psychological distress has been shown in a targeted sample of mild distressed 
breast cancer survivors, there is limited evidence for the effectiveness and 
acceptance of such an intervention in cancer care under ‘real world conditions’ 
[46]. 
 
Unfortunately, no evidence of a benefit of Living with lymphoma in an untargeted 
sample was found in this thesis. Access to Living with lymphoma did not increase 
self-management skills or satisfaction with information provision, and did not 
reduce psychological distress. The findings in this thesis thus differ from the 
findings regarding the BREATH intervention [43]. The major difference between 
the BREATH intervention and Living with lymphoma is the population to whom the 
intervention was offered. In this thesis, however, it was explicitly the aim to 
investigate the effects within a population-based setting without prior screening 
for distressed symptoms, as this format has the greatest potential to enable 






Regarding the uptake of the intervention, of those with access to Living with 
lymphoma only 36% actually signed up and even among them, the actual use of 
the intervention was minimal. Low intervention uptake rates (i.e., logging into the 
intervention) and low levels of adherence (i.e., completing modules of the 
intervention) are known to limit the potential impact of an intervention [47]. When 
patients were asked about their uptake and adherence, they indicated that they 
felt well and were not in need of an intervention. This corresponds to the small 
proportion of psychologically distressed patients within a web-based sample (15%). 
This percentage was significantly lower than observed within the previously 
investigated, observational lymphoma cohort (25%), suggesting that web-based 
participants may represent the more healthy patients with fewer adverse problems 
and not the patients who might be in need for an intervention to reduce 
psychological distress. On the other hand, a meta-analysis investigating the uptake 
and adherence of psychological interventions targeting psychological distress for 
cancer patients demonstrated that patients who were screened and identified as 
psychologically distressed were less likely to accept intervention than unselected 
patients [48]. Thus, the uptake was lower in studies that recruited patients scoring 
above the cutoff for psychological distress, compared to studies that recruited 
unselected patients. Although this suggests that unselected patients were more 
likely to accept such interventions, there is no evidence that greater intervention 
effects could be found among unselected patients. The results in this thesis, 
however, suggest that unguided web-based self-management interventions may 
not be effective in reducing psychological distress within a population-based, 
untargeted setting, but mainly in a targeted group. More research is needed to 
understand barriers to acceptance of psychosocial support, particularly since it has 
been demonstrated that uptake rates were lower for psychologically distressed 
patients [48].  
 
Furthermore, our findings indicate that older, female, and medium or low educated 
patients were underrepresented in the web-based RCT sample. These findings 
suggest that results from the RCT may not be simply generalized to the target 
population. The representativeness of the sample and the generalizability of the 











The studies presented in this thesis have several methodological strengths and 
limitations, which have been previously described in the different chapters. In this 
section, the most important methodological considerations of the LIVE trial are 
discussed in more detail, and suggestions to advance future studies are provided. 
 
RCT embedded within a population-based registry  
In this thesis, an RCT was conducted to examine the effectiveness of PRO feedback 
with or without access to Living with lymphoma on psychological distress, self-
management skills, and satisfaction with information provision. RCT participants 
were individually randomized to avoid bias by distributing the characteristics of 
patients that may influence outcome randomly between the three RCT arms49: (1) 
standard care; (2) standard care plus PRO feedback; (3) standard care plus PRO 
feedback with access to the web-based self-management intervention Living with 
lymphoma.  
 
In addition to a randomized controlled design, we chose for a pragmatic approach. 
As opposed to explanatory RCTs – which are designed to investigate the efficacy 
of an intervention under optimal, highly controlled conditions – pragmatic RCTs 
are designed to investigate the effectiveness of an intervention in a real-world 
setting [50,51]. In a pragmatic RCT it is important to align with clinical practice by 
the way in which you offer your intervention and without too many inclusion and 
exclusion criteria. Thus, exclusion criteria in our RCT were minimal, patients could 
use the interventions in the way they wanted to, and those in the standard care 
arm were not restricted regarding the way they searched for information about 
their disease and its consequences. Furthermore, our RCT was embedded within 
the population-based PROFILES registry [52], that enables PRO data collection 
management and linking these data to clinical data from the Netherlands Cancer 
Registry (NCR). In our RCT, the population-based NCR was used to select all 
patients who were diagnosed with lymphoma within a specific time frame in 
thirteen hospitals in the Netherlands and study eligibility was verified by their 
hematologists. Eligible patients were invited to participate and complete a 
questionnaire. Those who completed the web-based questionnaire participated in 
the RCT, whereas paper respondents were only observationally followed within the 
PROFILES lymphoma registry. The most important advantage of an RCT within a 





are maximized. As patients who participated in the BREATH trial – were Living with 
lymphoma was based on – were screened for psychological distress prior to the 
intervention, and the intervention was provided under slightly controlled 
conditions [43,44], it remained unclear what the effects of such intervention would 
be in a population-based setting. The population-based setting is essential for the 
evaluation of the effectiveness of PRO feedback and a web-based self-
management intervention, as there is a lack of evidence that such interventions are 
applicable in daily clinical practice. 
 
A pragmatic RCT however also has a number of methodological challenges that 
need to be considered. Pragmatic RCTs require access to more diverse clinical 
settings in order to increase the external validity and relevance of the outcomes 
[51]. In our RCT, patients were selected from thirteen – academic and community 
– hospitals throughout the Netherlands. Furthermore, both patients with 
aggressive and indolent lymphoma were invited to participate, so our RCT sample 
represents patients with curable lymphoma who have to cope with living after 
cancer, as well as patients with incurable lymphomas, who have to cope with living 
with cancer. Moreover, the interventions were designed in close and ongoing 
collaboration with relevant stakeholders [51] including psychologists, hematologist, 
researchers, and patients.  
 
Response rates  
This thesis reports data collected from two studies, namely a previously 
investigated, observational lymphoma cohort (Chapter 3 and 4) and the 
prospective longitudinal LIVE trial (Chapter 2, 5, 6 and 7). The response rate in 
the retrospective study was approximately 70%, which was relatively high. In the 
RCT the response rate was considerably lower, approximately 50%. Although 
similar patient groups were invited via comparable recruitment procedures, 
considerable differences in response rates exist. These differences may be 
explained by the knowledge that the more information is disclosed about a study 
– which is obviously more for an RCT than for an observational study – the greater 
the proportion of non-respondents [53]. Patients who were invited for the RCT 
received a lot of information, especially on participation in an RCT and 
randomization procedures. The amount of information, as well as the knowledge 
of being randomized when completing a web-based questionnaire may have 
deterred patients from participating. In addition, it is known that participation and 







past years because potential participants are faced with an increasing number of 
requests to participate in studies [54-55]. This overload may result in patients 
refusing to participate in studies [56].  
 
Another limitation with RCTs is loss to follow-up. Achieving a high response rate to 
follow-up questionnaires is important for study validity. However, in most 
longitudinal studies some loss to follow-up is considered to be inevitable. The 
findings in this thesis indicate that, after 4 months, approximately 85% of RCT 
participants completed the follow-up questionnaire, of whom 75% completed the 
follow-up questionnaire after one year, which is approximately 64% of the total 
RCT participants. This one year follow-up response rate was comparable with 
response rates of the previously investigated, observational lymphoma cohort for 
the second questionnaire, which varied between 50-67%. Furthermore, unequal 
loss of participants from different arms in an RCT results in attrition bias. 
Nevertheless, there was no difference among losses in the three arms in our RCT, 
decreasing the probability of attrition bias.  
 
Generalizability of the results 
As previously mentioned, pragmatic RCTs are designed to investigate the 
effectiveness of an intervention in a real-world setting [50,51]. Although all eligible 
patients from a population-based sample were selected and invited for 
participation, the findings in this thesis indicate that older, female, and medium or 
low educated patients were underrepresented in the RCT. While the RCT may yield 
accurate estimates of the effect of the interventions for those who participated in 
the RCT – mainly younger, male, and highly educated patients – it does not yield 
information about the effects in the target population and therefore, the findings 
in this thesis may not be simply generalizable to all patients with lymphoma. The 
results of this thesis indicate that it is difficult to recruit a sample that is 
representative of all patients with lymphoma, especially in an RCT for a web-based 
intervention. It is expected however that the RCT sample reflects the part of the 
population that is interested in engaging in a web-based intervention. 
 
The findings in this thesis indicate that RCT participants were more often male (70% 
vs 60%), highly educated (50% vs 20%), and had a partner (84% vs 77%) than 
respondents of the previously investigated observational cohort study. It has been 
demonstrated that lower education was associated with a decreased willingness to 





patients within the RCT – as only 3% was lower educated – could be that those 
patients may not understand the information and therefore not participated in the 
RCT. The use of multimedia (e.g., video, audio, and graphics), for example, may 
allow complex information to be presented in a simple format comprehensible 
even to those with low literacy skills [58]. Another way to make the intervention 
better accessible to lowly educated individuals may be through commissioning 
someone who guides them through the intervention. 
 
In addition, patients in the cohort study reported psychological distress 
considerably more often than patients who participated in the RCT (26% vs 15%, 
respectively). These findings suggest that the discrepancies between the previously 
investigated, observational cohort study and the RCT may be based on patient 
selection. It appears that especially those who may need the intervention the least, 
actually participated in the RCT. Furthermore, up to 20% of respondents of the 
prospective longitudinal study, in which the RCT was embedded, had no access to 
the Internet. As access to the Internet is necessary – but not sufficient – to benefit 
from web-based interventions, these findings suggest that not all patients who may 
benefit from psychological interventions could be reached via the Internet.  
 
Moreover, as the findings in this thesis only reflect the effects of the intervention 
on patients with lymphoma, it remains unclear whether similar effects would be 
obtained among patients with different cancer types. Previous research indicated 
that perceived receipt of information differed for different cancer types [59], which 
may be explained by differences in, for example, age, sex, and severity of the 
disease. More research is needed to examine the impact of the interventions on 
patients with different cancer types. 
 
Measures  
All outcomes in this thesis were self-reported and thus subjective. While PROs are 
deemed essential in the evaluation of psychological interventions, it would also be 
valuable to have some more objective data. For example, as healthcare use was 
self-reported, it remains unclear how often and for what reasons healthcare 
services were really used. Similarly, comorbid conditions were self-reported by the 
patients. This way to collect health information only represents conditions known, 
memorized and openly reported by the patients [60]. Therefore, it remains unclear 







would be interesting to compare outcomes of self-reported data to more objective 
data, for example, from medical records or pharmacy data.  
 
Furthermore, the outcome measures in the RCT were selected to investigate the 
effectiveness of the interventions, but not how patients anticipated on the extra 
information they received from the PRO feedback or self-management 
intervention. Although the results of this thesis indicated that patients who 
consulted the PRO feedback, reported more contacts with their GP, it remains 
unclear whether it was really the PRO feedback that motivated them to contact the 
GP. In line with the previous paragraph, it would be useful to ask patients for what 
reasons they contacted the GP. In addition, it would have been interesting to ask 
RCT participants how they felt after viewing the PRO feedback and what actions 
they have taken thereafter, in order to provide more information about the impact 
of the PRO feedback on patients.  
 
Outcomes in both the cohort study and the RCT were furthermore generally very 
much focused on the negative effects of cancer and its treatment. In recent years, 
patients have regularly stated that they believe that our research focuses too much 
on the negative effects of cancer. The findings in this thesis suggest that most 
patients are able to cope with the disease and its consequences. This may be due 
to a high level of resilience, which refers to the ability to maintain or restore 
relatively stable psychological and physical functioning when confronted with 
stressful life events and adversities [61]. In addition, a cancer diagnosis can trigger 
positive life changes in survivors (e.g., a better appreciation for life or a better 
understanding what is most important in their life) [62,63]. These positive changes 
during the disease trajectory are commonly referred to as posttraumatic growth 
[64,65]. For future research, it would therefore be interesting to investigate factors 
related to resilience or posttraumatic growth among cancer survivors. This also 
provides patients with an opportunity to share more positive experiences of 
receiving a cancer diagnosis.  
 
Clinical relevance 
Measures of statistical significance quantify the probability that the study results 
are due to chance. Although statistical significance is of importance when the 
impact of an intervention is evaluated, it is also important to look at clinical 
relevance. Clinical relevance reflects whether a change makes a real difference to 





statistical significance testing, this is often lacking for evaluation clinical relevance 
[66]. However, for some questionnaires evidence-based guidelines have been 
developed to determine whether differences in scores are clinically relevant for 
patients [67]. When such guidelines are lacking, a cut-off of half a standard 
deviation (0.5 SD) can be used to determine clinically relevant differences [68]. 
When using this ‘rule of thumb’, there was no clinically relevant effect of the 
interventions observed in the RCT. Nevertheless, it is mostly the judgement of the 
patient which decides whether a result is clinically relevant or not. For example, I 
received a phone call from a young women who participated in the RCT and 
consulted the PRO feedback. She experienced some persistent symptoms and 
found out that her symptoms were above average. The PRO feedback made her 
more aware of her symptoms and motivated her to take action and contact an 
AYA outpatient clinic – intended for all adolescents and young adults who have 
had cancer at the age of 18 to 35 years – to discuss these symptoms with a 
healthcare provider. In addition, I spoke with another female patient who had an 
indolent NHL and received active surveillance. She had experienced reasonable 
fatigue for some time and was unsure whether this was normal for her disease. The 
PRO feedback demonstrated that fatigue was often experienced by patients with 
lymphoma. This reassured her and she told me she was no longer worried about 
her fatigue. It would have been interesting to ask an open question in the follow-
up questionnaire about the evaluation of the interventions by the patients. 
Unfortunately, information about the evaluation is missing. Therefore, we were not 
able to make conclusive statements about the clinical relevance of the interventions 
on patients’ well-being.  
IMPLICATIONS FOR CLINICAL PRACTICE AND FUTURE DIRECTIONS 
 
PRO feedback to patients 
Previous research demonstrated that feedback from PROs could lead to improved 
symptom detection and increased dialogue about symptoms and problems 
between patients and healthcare providers [40,69-77]. In the majority of studies, 
PRO feedback however was provided to healthcare providers, such as physicians 
or nurse practitioners, and not directly to patients. In contrast, as it was the wish of 
patients to get insight in their own PRO data, we developed an application within 
the PROFILES registry to provide PRO feedback directly to patients and not to 
healthcare providers. Initially, healthcare providers were reluctant, as they expected 







resulting in increased healthcare use. However, providing PRO feedback to patients 
may help them to either reassure that what they experience is ‘normal’ or may 
motivate them to take action and discuss their symptoms with a healthcare 
provider. Providing PRO feedback directly to patients may increase patient 
involvement and help patients to feel more in control of their care, as our patient-
centered focus depends on patients actively communicating their concerns. This 
approach recognized that patients’ and healthcare providers’ perspectives 
regarding needs and symptoms can be meaningfully different [78-79]. In addition, 
although healthcare providers do not encourage an intervention that leads to an 
increase in the use of healthcare services, early recognition of adverse problems 
and appropriate referral to the right care services may eventually contribute to 
decreased use of medical healthcare services.  
 
Thus, as PRO feedback meets the wishes of patients and appears not to increase 
patients’ worries and fears, we would recommend implementing PRO feedback to 
patients with cancer in daily clinical practice, although substantial evidence of a 
benefit of PRO feedback on PROs is lacking. The PRO feedback application and 
algorithms have already been developed in our PROFILES system and therefore, it 
is relatively easy to adapt the feedback for patients with different cancer types. 
Nevertheless, it is important to take into account that there is sufficient normative 
data available to make comparisons with peers, as this comparison was evaluated 
as the most valuable part of the feedback intervention. At present, the PRO 
feedback has already been adapted for patients with colorectal, esophageal and 
stomach cancer. This allows all new patients with lymphoma, colorectal, 
esophageal, or stomach care who participate in observational studies to have 
access to their own PRO data. In addition, the PRO feedback for patients with 
lymphoma is already being used in daily clinical practice in specific hospitals.  
 
In the best case, PRO feedback is shared with both patients and healthcare 
providers. For healthcare providers, a summary of PRO scores would be 
implemented in the electronic health record so that healthcare providers will be 
able to follow patients’ functioning, symptoms, and emotional well-being jointly 
over time. Furthermore, rather than assessing outcomes after treatment, and using 
it primarily for research purposes, the goal would be to have PROs discussed with 
patients during their office visit. It can then be compared to normative values for 
similar conditions, and for patients and healthcare providers to use this data to 





[80]. Completion of PRO measures when responses are fed back to healthcare 
providers can signal to the patient that they feel someone is interested in their 
feelings and gives them ‘permission’ to share or raise issues with healthcare 
providers [81]. Previous literature showed that both patients and healthcare 
providers express satisfaction with using PRO information in clinical care [82,83]. 
Thinking more broadly, shared PROs could be linked with other health data and 
aid in value-based initiatives [80], as in the era of value-based oncology care, 
stakeholders are increasingly interested in PRO findings as a guide for clinical, 
regulatory, and reimbursement decisions [84]. Future research should determine 
whether PRO feedback to both patients and healthcare providers has a beneficial 
effect on patients’ symptoms and functioning, or may even have clinical benefits.  
 
Moreover, the findings in this thesis suggest that almost a quarter of participating 
patients did not want access to their own PRO data. Those who did not access the 
PRO feedback appeared to be less self-efficacious. It has been demonstrated that 
those patients with low self-efficacy feel less confident in their abilities to make 
better decisions in face of potentially negative information and be less likely to 
obtain such information [85]. Therefore, it is of great importance that patients could 
decide for themselves whether or not they want to access the PRO feedback and 
whether or not they want to share their data with their healthcare provider. This 
helps to ensure that patients do not see the PRO feedback when they do not want 
to.  
 
Web-based self-management interventions 
Self-management has been proposed as a strategy to help patients with cancer 
optimize their health and well-being during survivorship. Previous literature 
demonstrated variable effects of self-management on various outcomes [86]. In 
addition, interventions that are self-directed or guided by patients may hold 
promise as they allow patients to engage with interventions as they need [87]. In 
its current form, we would however not recommend implementation of the web-
based self-management intervention – Living with lymphoma – for all patients with 
lymphoma. First, the results of this thesis revealed no substantial evidence of a 
beneficial effect of the intervention. No differences were observed in psychological 
distress, self-management skills, and satisfaction with information provisions 
between patients who had access to Living with lymphoma and those who did not. 
Second, only one-third of patients logged into the intervention, of whom only a 







potential of effective treatment is that individuals are willing to use the intervention 
[88]. Low uptake and low levels of adherence not only limited the potential impact 
of the intervention, but also suggest that patients are unwilling to use such 
interventions. Although previous literature showed that uptake rates of web-based 
psychosocial interventions implemented in real-life settings under less-structured 
and monitored conditions are known to be limited [88], it has also been 
demonstrated that the uptake of psychosocial interventions to reduce 
psychological distress was higher among unselected patients, compared to 
patients scoring above the cutoff for psychological distress [48]. Supporting 
intervention adherence through weekly email or telephone calls providing 
guidance may be necessary to increase usage and completion of relevant modules 
of the web-based intervention. In addition, web-based interventions may need to 
be accompanied by counseling, as talking and interpersonal factors could be 
important in psychosocial interventions. Nevertheless, interventions that are 
unguided rather than requiring professional facilitation may hold promise as they 
may be cost-effective to deliver, allow the patient to engage with the intervention 
as they are ready and may also overcome geographical barriers [87]. Therefore, in 
clinical practice, interventions that need human assistance however may be more 
difficult to integrate into standard care given the required resources. Third, the 
timing of the intervention may be not optimal. Previous literature demonstrated 
that patients on treatment more frequently reported psychological distress 
compared with short- and long-term survivors [89]. Although our research typically 
focused on patients who were on average 14 months after diagnosis – and mostly 
finished primary treatment – interventions may be more effective closer to 
diagnosis or during active treatment, as patients are especially vulnerable to 
psychological distress in that specific time frame. Early intervention for reducing or 
preventing the development of psychological distress may improve patients’ 
quality of life throughout the treatment period [90]. Therefore, a web-based self-
management intervention for psychological distress may be more appropriate as 
a population-level intervention as part of a stepped care approach. A stepped care 
approach has the potential to improve the efficiency of psychosocial care. The 
central idea underpinning a stepped care approach is that patients with mild 
psychological problems are offered low intensity interventions including 
psychoeducation, self-help, counseling, or problem-solving treatment. For those 
who not respond to these approaches, or for those with more severe problems, 
more intensive treatment options may be appropriate [91]. More research is 





management intervention, before conclusions can be drawn about the 
effectiveness of Living with lymphoma within a population-based setting. 
 
Moreover, when effective, web-based self-management interventions have the 
potential to be highly cost-effective, as they can be delivered at scale across large 
populations, with relatively low additional costs per additional user [92]. Although, 
we have not formally studied cost-effectiveness of the intervention, it was an 
important issue in our considerations of whether or not to implement the 
intervention. Two types of costs are related to the intervention: those incurred 
during the development of the intervention; and those related to ongoing delivery 
and maintenance of the intervention. The developmental costs, although 
considerable, are unlikely to be repeated if the intervention would be adopted in 
routine care. Conversely, if the intervention were to be widely implemented into 
routine care, costs of delivery, maintenance and updating of the intervention would 
be required on an on-going basis. The findings in this thesis suggest that the costs 
of implementation of the intervention into routine care would be much higher than 
the potential benefits, as no beneficial effects of the intervention were observed. It 
is important to keep cost-effectiveness in mind when large scale implementation 




Based on the wishes of patients to get insight in their own data, we developed an 
application to provide feedback on PRO directly to patients. The findings in this 
thesis demonstrated that providing PRO feedback directly to patients did not have 
adverse effects on patients’ well-being and may be a useful tool to increase 
symptom detection and motivate patients to discuss their symptoms with a 
healthcare provider, as PRO feedback increased the number of GP contacts. 
Hence, we would recommend both expansion of the PRO feedback to other cancer 
types as well as implementation in daily clinical practice. Moreover, the results of 
this thesis showed that an unguided web-based self-management intervention, 
with low uptake and low levels of adherence, did not have beneficial effects on 
patients’ well-being. At present, we would therefore not recommend 
implementation of Living with lymphoma in routine care, as first more research is 







management intervention, before conclusions can be drawn about the 
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SUMMARY OF RESULTS 
 
The current thesis describes the process from making an inventory of factors 
associated with psychological distress among lymphoma survivors to the 
development and evaluation of an intervention that aims to increase self-
management skills, satisfaction with information provision, and ultimately reduce 
psychological distress. In this chapter, the main findings of the studies described in 
this thesis are summarized. 
Part I Inventory: factors associated psychological  
The first part of this thesis consists of an inventory of sociodemographic, clinical 
and psychological factors that are associated with psychological distress among 
lymphoma survivors (Chapter 2). Four hundred and fifty-six patients participated 
in this study. We observed that, besides age and comorbid conditions, both 
personality traits, in particular neuroticism, and coping strategies including anxious 
preoccupation, helplessness/hopelessness, and avoidance were significantly 
associated with psychological distress. Although neuroticism was the greatest 
factor associated with psychological distress, this association was partially explained 
by coping strategies. The regression model, in which personality traits and coping 
strategies were added to sociodemographic and clinical characteristics, explained 
half of the total variance in psychological distress among patients with lymphoma. 
Education, cancer type and active treatment were not associated with 
psychological distress. 
 
Next, we compared the use of healthcare services by lymphoma survivors with that 
of an age- and sex-matched normative population. In addition, we compared the 
use of healthcare services between those with and without psychological distress 
(Chapter 3). It was observed that lymphoma survivors (N=1,444) reported more 
medical contacts (i.e., contacts with the general practitioner (GP) or medical 
specialist) compared to an age- and sex-matched normative population without 
cancer (N=563). In addition, we observed that those who experienced 
psychological distress (N=345) had even more contacts with their GP and medical 
specialist. Furthermore, we observed that psychologically distressed patients not 
only had an increased use of medical services, but also received psychosocial care 
more often. Nevertheless, more than half of those scoring above the cutoff for 
psychological distress did not receive psychosocial care. Especially among older 





survivors seemed more often psychologically distressed, they received 
psychosocial care somewhat less often.  
Part II Intervention: Lymphoma InterVEntion [LIVE] 
The second part of the current thesis is about the development and evaluation of 
an intervention that aims to increase self-management skills and satisfaction with 
information provision and reduce psychological distress. We started to investigate 
whether patients with lymphoma wished to receive feedback on their patient-
reported outcomes (PROs), including the option to compare their PRO summary 
scores with those of their peers, and how this feedback was evaluated (Chapter 
4). We invited 64 patients participating in a lymphoma cohort who were eligible 
for a follow-up questionnaire and gave them the option to receive PRO feedback. 
Of the responding patients (N=45), approximately 80% wished to receive feedback 
on their PROs. The vast majority (94%) compared their scores with those of a 
lymphoma reference cohort, whereas approximately 64% compared their scores 
with those of a normative population without cancer. All patients wished to receive 
feedback on their general health-related quality of life, while 81-92% of the patients 
wished to receive feedback on their functioning scores (i.e., physical, emotional, 
cognitive, social), fatigue, neuropathy, anxiety, and depressive symptoms. 
Approximately 97% of the patients who received feedback on their PROs assessed 
the feedback as a useful tool, with reassurance and knowledge about their own 
functioning in relation to what is “normal” being the most frequently mentioned 
reasons.  
 
In Chapter 5, the rationale and study design of the Lymphoma InterVEntion (LIVE) 
trial were presented. The LIVE trial was conducted to increase self-management 
skills and satisfaction with information provision and reduce psychological distress. 
The LIVE trial consists of two interventions: 1) feedback to patients on their PROs, 
and 2) a web-based self-management intervention named Living with lymphoma. 
The PRO feedback enabled patients to monitor their symptoms and compare their 
scores with those of their peers, which could have either reassured them that what 
they experienced was ‘normal’ or could have empowered them to take action. The 
Living with lymphoma intervention is based on psycho-education and cognitive 
behavioral therapy components and is an adaptation from the evidence-based 
BREAst cancer e-healTH (BREATH) intervention. The LIVE trial was designed as a 
non-blinded randomized controlled trial with three arms. Care as usual (CAU) plus 







CAU plus access to PRO feedback (arm 2) were compared to CAU (arm 1). The 
LIVE trial was embedded within the Patient Reported Outcomes Following Initial 
treatment and Long term Evaluation of Survivorship (PROFILES) registry that 
enables PRO data collection management and linking these data to clinical data 
from the Netherlands Cancer Registry (NCR). Patients with lymphoma from various 
hospitals in the Netherlands were included and asked to complete questionnaires 
at four points in time: baseline (T0; 6 to 15 months after diagnosis), after 16 weeks 
(T1; post-intervention), after 12 months (T2), and after 24 months (T3). Primary 
outcomes were defined as self-management skills, satisfaction with information 
provision, and psychological distress. Based on new insights that psychologically 
distressed patients reported increased healthcare use, healthcare use was added 
as primary outcome.  
 
The main effects of feedback to patients on their PROs and access to a web-based 
self-management intervention named Living with lymphoma on patients’ self-
management skills, satisfaction with information provision, psychological distress, 
and healthcare use were described in Chapter 6. No effects of PRO feedback on 
psychological distress, self-management skills, satisfaction with information 
provision, and healthcare use were found. However, the PRO feedback also had 
no negative impact on patients’ well-being. Nevertheless, the PRO feedback meets 
the wishes of patients to gain insight in their PROs. The PRO feedback was viewed 
by 77% of those who had access to it. The uptake of Living with lymphoma was 
relatively low. Only 36% of those with access, actually registered and accessed the 
intervention, and 16 patients opened at least one part of the intervention. Because 
the uptake and adherence of Living with lymphoma was very limited, no definite 
conclusions about the effectiveness of Living with lymphoma in a population-based 
sample can be drawn yet.  
 
The reach of a web-based self-management intervention within the context of the 
LIVE trial was examined in Chapter 7. Patients were recruited from the population-
based Netherlands Cancer Registry (NCR) that routinely collects data on 
sociodemographic and clinical characteristics, which provided a unique insight into 
characteristic differences between trial participants and non-participants in order 
to address the reach of this intervention. Patients who completed the web-based 
questionnaire were automatically enrolled in the RCT, whereas paper questionnaire 
completers were observationally followed in the PROFILES registry. A total of 1193 





were invited for participation after hematologist verified their eligibility. From the 
total population-based sample of eligible patients who were invited to participate, 
25% participated in the RCT (N=227). RCT participants were younger, more often 
male, and more highly educated than nonparticipants. Therefore, RCT participants 
may represent a minority of the target population, which may limit external validity 
of RCT results and translation to routine care. 
Methodological considerations and implications for clinical practice and 
future research 
The methodological considerations of the studies, as well as implications for clinical 
practice and future research were outlined in Chapter 8. Although the LIVE trial 
was designed to investigate the effectiveness of PRO feedback and the Living with 
lymphoma intervention in a real-world setting, it was observed that older, female 
and lower educated patients were underrepresented, which limits the 
generalizability of our results. More research is needed into reasons why some 
patients were not reached, and how they could be reached in the future. In 
addition, as uptake and adherence rates were relatively low, more research is 
needed to investigate the optimal format and delivery of Living with lymphoma, 
before conclusions can be drawn about its effectiveness within a population-based 
setting. Therefore, at present, we would not recommend implementation of Living 
with lymphoma in routine care. Conversely, as PRO feedback meets the wishes of 
patients and appears not to increase patients’ worries and fears, we do recommend 
implementation of PRO feedback to patients with cancer in daily clinical practice.  
 
Conclusions 
Providing PRO feedback directly to patients meets patients’ wishes to have insight 
in their own PROs and did not increase worries or fears. PRO feedback can be a 
useful tool to increase symptom detection and motivate patients to discuss their 
symptoms with a healthcare provider, as PRO feedback increased the number of 
GP contacts. In addition, no beneficial effects of an unguided web-based self-
management intervention – Living with lymphoma – in a population-based setting 
were observed. The uptake and adherence of such an intervention in a population-










(SUMMARY IN DUTCH) 
 
Dit proefschrift beschrijft het proces van het inventariseren van factoren die 
samenhangen met psychologische stress bij (ex-)patiënten met lymfeklierkanker 
tot de ontwikkeling en evaluatie van een interventie die gericht is op het vergroten 
van de zelfmanagementvaardigheden, tevredenheid van informatievoorziening, 
en het verminderen van psychische stress. In dit hoofdstuk worden de belangrijkste 
bevindingen uit dit proefschrift samengevat. 
Deel I Inventarisatie: factoren die samenhangen met psychologische stress 
Het eerste deel van dit proefschrift bestaat uit een inventarisatie van factoren die 
samenhangen met psychologische stress bij (ex-)patiënten met lymfeklierkanker. 
In hoofdstuk 2 worden sociodemografische, klinische en psychologische factoren 
gepresenteerd die samenhangen met psychologische stress. In totaal namen 456 
(ex-)patiënten met lymfeklierkanker deel aan dit onderzoek. De gemiddelde leeftijd 
van de deelnemers was 65 jaar, 64% was man en 17% had te maken met 
psychologische stressklachten. We constateerden dat een jongere leeftijd en de 
aanwezigheid van comorbiditeit – het hebben van een andere ziekte naast kanker, 
zoals suikerziekte of hart- en vaatziekten – samenhingen met meer psychologische 
stress bij (ex-)patiënten met lymfeklierkanker. Ook vonden we dat persoonlijkheid 
en copingstijlen samenhingen met psychologische stress. Zo kwam naar voren dat 
mensen die hoog scoren op neuroticisme meer psychologische stress ervoeren en 
zagen we dat copingstijlen die gekenmerkt werden door hulpeloosheid en 
angstige preoccupatie samenhingen met meer psychologische stress, terwijl 
vermijding gerelateerd leek aan minder psychologische stressklachten. 
 
In hoofdstuk 3 hebben we het zorggebruik van patiënten met lymfeklierkanker 
vergeleken met dat van een normpopulatie zonder kanker. Tevens hebben we 
gekeken naar de verschillen in zorggebruik tussen patiënten met en zonder 
psychische stress. Er deden in totaal 1,444 (ex-)patiënten met lymfeklierkanker mee 
aan deze studie. De normpopulatie bestond uit 563 personen. We vonden dat (ex-
)patiënten met lymfeklierkanker gemiddeld meer medische contacten hadden 
(d.w.z. contacten met de huisarts of medisch specialist) dan de normpopulatie 
zonder kanker. Ook zagen we dat patiënten met psychologische stress meer 
medische contacten hadden dan zij die geen psychologische stress ervoeren. 





medische zorg, maar ontvingen ook meer psychosociale zorg. Desondanks 
ontving meer dan de helft van de patiënten met psychologische stress geen 
psychosociale zorg. Vooral onder ouderen leek de psychosociale zorg niet 
optimaal. Hoewel oudere patiënten in dit onderzoek vaker psychologische stress 
ervoeren, ontvingen zij minder vaak psychosociale zorg.  
 
Deel II Interventie: Lymphoma InterVEntion [LIVE] 
Het tweede deel van dit proefschrift bestaat uit de ontwikkeling en evaluatie van 
een interventie die gericht is op het vergroten van zelfmanagementvaardigheden 
en de tevredenheid met de informatievoorziening, en het verminderen van 
psychologische stress. In hoofdstuk 4 begonnen we met onderzoeken of 
patiënten met lymfklierkanker een terugkoppeling zouden willen ontvangen van 
hun patiëntgerapporteerde uitkomsten, inclusief de optie om hun scores te 
vergelijken met anderen, en hoe deze terugkoppeling werd geëvalueerd. We 
hebben voor dit onderzoek 64 (ex-)patiënten met lymfeklierkanker uitgenodigd 
die reeds deelnamen aan een lopend studiecohort en in aanmerking kwamen voor 
een vervolgvragenlijst. Zij kregen de optie om een terugkoppeling van hun 
patiëntgerapporteerde uitkomsten – zoals kwaliteit van leven, functioneren en 
symptomen – te ontvangen. Van de 64 uitgenodigden namen 45 patiënten deel 
aan dit onderzoek, van wie ongeveer 80% een terugkoppeling van hun uitkomsten 
wilde ontvangen. De meerderheid (94%) wilde zijn of haar scores vergelijken met 
die van andere patiënten met lymfeklierkanker en 64% koos voor een vergelijking 
met de normpopulatie zonder kanker. Alle patiënten, die een terugkoppeling van 
hun scores wilden ontvangen, wilden inzicht in hun scores op algehele kwaliteit 
van leven, terwijl 81% tot 92% van de patiënten een terugkoppeling wilde 
ontvangen van hun scores op functioneren (lichamelijk, emotioneel, cognitief, 
sociaal), vermoeidheid, neuropathie (tintelingen en/of doof gevoel in handen en 
voeten), angst en depressieve symptomen. Ongeveer 97% van de patiënten die 
een terugkoppeling van zijn of haar patiëntgerapporteerde uitkomsten had 
ontvangen, vond de terugkoppeling nuttig. De terugkoppeling van hun uitkomsten 
stelde hen gerust of gaf hen kennis over het eigen functioneren in relatie tot wat 
‘normaal’ is.  
 
In hoofdstuk 5 worden de aanleiding voor en de opzet van de Lymphoma 
InterVEntion [LIVE] studie gepresenteerd. De LIVE studie werd opgezet om 
zelfmanagementvaardigheden en de tevredenheid met de informatievoorziening 







twee interventies: 1) een terugkoppeling aan patiënten van hun patiënt-
gerapporteerde uitkomsten en 2) een online zelfmanagementinterventie Leven 
met lymfeklierkanker. De terugkoppeling stelde patiënten in staat hun symptomen 
monitoren en hun scores te vergelijken met die van andere patiënten of een 
normpopulatie zonder kanker. Dit zorgde voor geruststelling dat wat ervaren werd 
‘normaal’ was, of stelde hen in staat actie te ondernemen. De online 
zelfmanagementinterventie Leven met lymfeklierkanker is gebaseerd op psycho-
educatie en onderdelen uit de cognitieve gedragstherapie. Leven met 
lymfeklierkanker is een aanpassing vanuit de online zelfmanagementinterventie Op 
adem na borstkanker, die reeds effectief is gebleken in het verminderen van milde 
psychologische stress bij patiënten met borstkanker. De LIVE studie is opgezet als 
een gerandomiseerde gecontroleerde studie met drie studiearmen. Gebruikelijke 
zorg plus toegang tot terugkoppeling van patiëntgerapporteerde uitkomsten én 
de Leven met lymfeklierkanker interventie (arm 3) en gebruikelijke zorg plus 
toegang tot terugkoppeling van patiëntgerapporteerde uitkomsten (arm 2) 
werden vergeleken met gebruikelijke zorg (arm 1). De LIVE studie was ingebed in 
PROFIEL-studie, een infrastructuur die het mogelijk maakt om gegevens te 
verzamelen over patiëntgerapporteerde uitkomsten en deze gegevens te 
koppelen aan de klinische gegevens uit de Nederlandse Kankerregistratie (NKR). 
Patiënten met lymfeklierkanker uit verschillende ziekenhuizen in Nederland werden 
uitgenodigd en gevraagd om vragenlijsten in te vullen op vier tijdsmomenten: 
direct na de uitnodiging, na 16 weken (na de interventie), na 12 maanden en na 24 
maanden. De primaire uitkomstmaten werden gedefinieerd als zelfmanagement-
vaardigheden, tevredenheid met de informatievoorziening en psychologische 
stress. Op basis van nieuwe inzichten, waarin naar voren kwam dat patiënten met 
psychologische stress meer zorg gebruikten dan patiënten zonder psychologische 
stress, werd zorggebruik als primaire uitkomstmaat toegevoegd.  
 
In hoofdstuk 6 worden de resultaten met betrekking tot de effecten van de 
terugkoppeling van patiëntgerapporteerde uitkomsten en de online 
zelfmanagementinterventie Leven met lymfeklierkanker op zelfmanagement-
vaardigheden, tevredenheid met de informatievoorziening, psychologische stress 
en zorggebruik van (ex-)patiënten met lymfeklierkanker beschreven. We vonden 
geen effecten van de terugkoppeling van patiëntgerapporteerde uitkomen op 
psychologische stress, zelfmanagementvaardigheden, tevredenheid met de 
informatievoorziening en zorggebruik. Tevens vonden we dat het terugkoppelen 





van patiënten. De terugkoppeling komt tegemoet aan de wensen van patiënten 
om inzicht te krijgen in hun eigen patiëntgerapporteerde uitkomsten. De 
terugkoppeling van patiëntgerapporteerde uitkomsten werd door 77% van de 
patiënten bekeken. Het gebruik van Leven met lymfeklierkanker was veel lager. 
Slechts 36% van de patiënten die toegang hadden, hebben zich aangemeld en 16 
patiënten hebben tenminste een onderdeel van de interventie geopend. Omdat 
het gebruik van de interventie relatief laag was, kunnen we nog geen harde 
conclusies trekken over de effecten van Leven met lymfeklierkanker op 
psychologische stress, zelfmanagementvaardigheden, tevredenheid met de 
informatievoorziening en zorggebruik. Hiervoor is eerst vervolgonderzoek nodig. 
 
In hoofdstuk 7 wordt het bereik van een online zelfmanagementinterventie 
binnen de context van de LIVE studie onderzocht. Patiënten werden geworven via 
de Nederlandse Kankerregistratie (NKR), waarin structureel sociodemografische en 
klinische gegevens worden verzameld van mensen die kanker hebben (gehad) in 
Nederland. Dit gaf een uniek inzicht in de verschillen tussen patiënten die wel 
deelnamen aan de gerandomiseerde gecontroleerde studie en patiënten die niet 
deelnamen en gaf ons de mogelijkheid om het bereik van de interventie te 
bepalen. Patiënten die de vragenlijst online invulden namen automatisch deel aan 
de gerandomiseerde gecontroleerde studie, terwijl patiënten die de vragenlijst op 
papier invulden enkel observationeel gevolgd werden. In totaal werden 1193 
patiënten met lymfeklierkanker geselecteerd uit de NKR. Nadat de betreffende 
hematologen akkoord hadden gegeven voor het benaderen van hun patiënten, 
werden 892 (75%) patiënten uitgenodigd voor deelname aan de studie. Uiteindelijk 
vulden 227 patiënten (25%) de vragenlijst online in en namen deel aan de 
gerandomiseerde gecontroleerde studie. Deze patiënten waren jonger, vaker man 
en hoger opgeleid dan mensen de vragenlijst op papier of helemaal niet invulden 
en dus niet deelnamen aan de gerandomiseerde gecontroleerde studie. Dit wees 
erop dat de patiënten in de gerandomiseerde gecontroleerde studie slechts een 
minderheid van de totale doelgroep vertegenwoordigden, wat mogelijk de externe 
validiteit of generaliseerbaarheid van de resultaten kan beperken, alsook de 
mogelijkheid om de resultaten te vertalen naar de dagelijkse klinische praktijk.  
 
De methodologische overwegingen en de implicaties voor de klinische praktijk en 
toekomstig onderzoek worden beschreven in hoofdstuk 8. De LIVE studie werd 
opgezet om de effectiviteit van een terugkoppeling van patiëntgerapporteerde 







de echte wereld te onderzoeken. Echter vonden we dat ouderen, vrouwen en lager 
opgeleide patiënten niet voldoende vertegenwoordigd waren in de studie, wat de 
generaliseerbaarheid van de onderzoekresultaten beperkt. Er is meer onderzoek 
nodig naar de redenen waarom sommige patiënten niet werden bereikt en naar 
hoe deze patiënten in de toekomst wel kunnen worden bereikt. Tevens is meer 
onderzoek nodig naar de optimale manier van het aanbieden van Leven met 
lymfeklierkanker, voordat er duidelijke conclusies kunnen worden getrokken over 
de effectiviteit van de interventie in de echte wereld, daar het gebruik slechts 
minimaal was. Er wordt daarom (nog) niet aangeraden de online zelfmanagement-
interventie Leven met lymfeklierkanker te implementeren in de dagelijkse klinische 
praktijk. Aan de andere kant kan de terugkoppeling van patiëntgerapporteerde 
uitkomsten worden geïmplementeerd in de dagelijkse klinische praktijk, daar het 
tegemoet komt aan de wensen van patiënten zonder dat het de zorgen en angsten 
rondom de ziekte lijkt te vergroten.  
 
Conclusie 
Het aan patiënten aanbieden van een terugkoppeling van patiëntgerapporteerde 
uitkomsten komt tegemoet aan hun wensen om meer inzicht te krijgen in hun 
uitkomsten zonder de zorgen en angsten rondom te ziekte te vergroten. De 
terugkoppeling van patiëntgerapporteerde uitkomsten kan een nuttig hulpmiddel 
zijn om symptomen beter te kunnen detecteren en patiënten te motiveren om hun 
symptomen met een zorgverlener te bespreken. Er werden geen effecten van de 
online zelfmanagement interventie Leven met lymfeklierkanker gevonden. Echter 
was het gebruik van de interventie relatief laag, wat de effectiviteit van de 









































“At times, our own light goes out and is rekindled by a 
spark from another person. Each of us has cause to 
think with deep gratitude of those who have lighted 
the flame within us.”  
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